Title: Modulation of paraoxonase 1 (PON1) activity and protein N-homocysteinylation by bisphosphonates in rats.
Journal: Chemico-biological interactions 20161125
Title: Bioactivity of Ti-6Al-4V alloy implants treated with ibandronate after the formation of the nanotube TiO2 layer.
Journal: Journal of biomedical materials research. Part B, Applied biomaterials 20121101
Title: Incidence of maxillary sinusitis and oro-antral fistulae in bisphosphonate-related osteonecrosis of the jaw.
Journal: Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 20121001
Title: Six months of parathyroid Hormone (1-84) administered concurrently versus sequentially with monthly ibandronate over two years: the PTH and ibandronate combination study (PICS) randomized trial.
Journal: The Journal of clinical endocrinology and metabolism 20121001
Title: The influence of ibandronate treatment on bone density and biochemical bone markers in patients with osteogenesis imperfecta.
Journal: Orthopedic reviews 20120904
Title: Oral bisphosphonate-related osteonecrosis of the jaws: Clinical characteristics of a series of 20 cases in Spain.
Journal: Medicina oral, patologia oral y cirugia bucal 20120901
Title: Efficacy of intravenously administered ibandronate in postmenopausal Korean women with insufficient response to orally administered bisphosphonates.
Journal: Journal of bone and mineral metabolism 20120901
Title: Time to onset of efficacy in fracture reduction with current anti-osteoporosis treatments.
Journal: Journal of bone and mineral metabolism 20120901
Title: Clinical trials of bisphosphonates in multiple myeloma.
Journal: Clinical advances in hematology & oncology : H&O 20120901
Title: Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20120801
Title: Prolonged administration of bisphosphonates is well-tolerated and effective for skeletal-related events in Chinese breast cancer patients with bone metastasis.
Journal: Breast (Edinburgh, Scotland) 20120801
Title: Once-monthly oral ibandronate provides significant improvement in bone mineral density in postmenopausal women treated with glucocorticoids for inflammatory rheumatic diseases: a 12-month, randomized, double-blind, placebo-controlled trial.
Journal: Scandinavian journal of rheumatology 20120801
Title: Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis.
Journal: Revista brasileira de reumatologia 20120801
Title: [Non-traumatic fractures at the end of a pregnancy: are there always of osteoporotic origin].
Journal: Praxis 20120704
Title: Monitoring of bone turnover markers does not improve persistence with ibandronate treatment.
Journal: Joint, bone, spine : revue du rhumatisme 20120701
Title: Bisphosphonate-related osteonecrosis of the mandible secondary to postural pressure.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20120701
Title: Adherence with intravenous zoledronate and intravenous ibandronate in the United States Medicare population.
Journal: Arthritis care & research 20120701
Title: Interpreting results from oncology clinical trials: a comparison of denosumab to zoledronic acid for the prevention of skeletal-related events in cancer patients.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20120701
Title: Management of osteoporosis among the elderly with other chronic medical conditions.
Journal: Drugs & aging 20120701
Title: SEOM guidelines for the treatment of bone metastases from solid tumours.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20120701
Title: Once-monthly oral ibandronate treatment in an adolescent with recurrent fractures and inadequately low bone mass.
Journal: Journal of paediatrics and child health 20120701
Title: Efficacy and safety of monthly oral minodronate in patients with involutional osteoporosis.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120601
Title: Efficacy of monthly oral ibandronate is sustained over 5 years: the MOBILE long-term extension study.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120601
Title: Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120601
Title: Clinical review. Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta-analysis.
Journal: The Journal of clinical endocrinology and metabolism 20120601
Title: Gastrointestinal bleeding following intravenous ibandronate administration.
Journal: Journal of pharmacy practice 20120601
Title: Monthly ibandronate for the prevention of bone loss in patients after liver transplantation.
Journal: Transplantation proceedings 20120601
Title: Bisphosphonates in multiple myeloma: a network meta-analysis.
Journal: The Cochrane database of systematic reviews 20120516
Title: Successful treatment of calcific uraemic arteriolopathy with bisphosphonates.
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20120514
Title: Multifactorial analysis of risk factors for reduced bone mineral density among postmenopausal women.
Journal: Archives of medical science : AMS 20120509
Title: 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis.
Journal: Joint, bone, spine : revue du rhumatisme 20120501
Title: Persistence and compliance of medications used in the treatment of osteoporosis--analysis using a large scale, representative, longitudinal German database.
Journal: International journal of clinical pharmacology and therapeutics 20120501
Title: Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.
Journal: Journal of managed care pharmacy : JMCP 20120501
Title: Bisphosphonates as antimyeloma drugs.
Journal: Leukemia 20120401
Title: Medication adherence and fracture risk among patients on bisphosphonate therapy in a large United States health plan.
Journal: Bone 20120401
Title: Patient-reported outcome instruments used to assess pain and functioning in studies of bisphosphonate treatment for bone metastases.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20120401
Title: [Simultaneous determination of alendronate, pamidronate, ibandronate and risedronate using ion chromatography with integrated pulsed amperometric detection].
Journal: Se pu = Chinese journal of chromatography 20120401
Title: Effect of dosing interval duration of intermittent ibandronate treatment on the healing process of femoral osteotomy in a rat fracture model.
Journal: Calcified tissue international 20120301
Title: An evaluation of the use of oral bisphosphonates and risk of esophageal cancer.
Journal: The Annals of pharmacotherapy 20120301
Title: Primary diagnosis of metastatic breast cancer in the third trimester of pregnancy: a case report and review of the literature.
Journal: The journal of obstetrics and gynaecology research 20120301
Title: [Bisphosphonates treatment in patients with osteoporosis].
Journal: Therapeutische Umschau. Revue therapeutique 20120301
Title: Spontaneous non-traumatic stress fractures in bilateral femoral shafts in a patient treated with bisphosphonates.
Journal: The Korean journal of internal medicine 20120301
Title: Phase I clinical study to select a novel oral formulation for ibandronate containing the excipient sodium N-[8-(2-hydroxybenzoyl) amino] caprylate (SNAC).
Journal: Die Pharmazie 20120301
Title: Question: In postmenopausal women with osteoporosis is once monthly oral ibandronate (150 mg) therapy preferred to once weekly oral bisphosphonate therapy.
Journal: The Journal of the Oklahoma State Medical Association 20120301
Title: Ibandronate and calcitriol reduces fracture risk, reverses bone loss, and normalizes bone turnover after LTX.
Journal: Transplantation 20120215
Title: Bisphosphonates and other bone agents for breast cancer.
Journal: The Cochrane database of systematic reviews 20120215
Title: Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro.
Journal: Clinical oral investigations 20120201
Title: Counting touching cell nuclei using fast ellipse detection to assess in vitro cell characteristics: a feasibility study.
Journal: Clinical oral investigations 20120201
Title: The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study.
Journal: Clinical oral investigations 20120201
Title: Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120201
Title: Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20120201
Title: Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120201
Title: [Pelvic pain in the athlete: not always that simple...].
Journal: Revue medicale suisse 20120125
Title: Alendronate and atrial fibrillation: a meta-analysis of randomized placebo-controlled clinical trials.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120101
Title: Intravenous ibandronate acutely reduces bone hyperresorption in chronic critical illness.
Journal: Journal of intensive care medicine 20120101
Title: Effect of monthly ibandronate on hip structural geometry in men with low bone density.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120101
Title: Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120101
Title: Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study.
Journal: European journal of endocrinology 20120101
Title: Impact of oral ibandronate 150 mg once monthly on bone structure and density in post-menopausal osteoporosis or osteopenia derived from in vivo μCT.
Journal: Bone 20120101
Title: Factors associated with treatment of women with osteoporosis or osteopenia from a national survey.
Journal: BMC women's health 20120101
Title: [The research on the expression and localization of multiple myeloma associated antigen MMSA-1].
Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology 20120101
Title: Exposure to bisphosphonates and risk of cancer: a protocol for nested case-control studies using the QResearch primary care database.
Journal: BMJ open 20120101
Title: Risedronate's Role in Reducing Hip Fracture in Postmenopausal Women with Established Osteoporosis.
Journal: Clinical medicine insights. Arthritis and musculoskeletal disorders 20120101
Title: A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence.
Journal: Patient preference and adherence 20120101
Title: Bilateral atypical insufficiency fractures of the proximal tibia and a unilateral distal femoral fracture associated with long-term intravenous bisphosphonate therapy: a case report.
Journal: Journal of medical case reports 20120101
Title: Epidemiological aspects of rheumatoid arthritis patients affected by oral bisphosphonate-related osteonecrosis of the jaws.
Journal: Head & face medicine 20120101
Title: Time associated with intravenous zoledronic acid administration in patients with breast or prostate cancer and bone metastasis.
Journal: Cancer management and research 20120101
Title: Effect of local zoledronate on implant osseointegration in a rat model.
Journal: BMC musculoskeletal disorders 20120101
Title: MiR-133a in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis.
Journal: PloS one 20120101
Title: Possible role of oral ibandronate administration in Osteonecrosis of the Jaw: a case report.
Journal: International journal of immunopathology and pharmacology 20120101
Title: Active Referral Intervention following Fragility Fractures Leads to Enhanced Osteoporosis Follow-Up Care.
Journal: Journal of osteoporosis 20120101
Title: Severe hypercalcemia due to teriparatide.
Journal: Indian journal of pharmacology 20120101
Title: Clinical utility of risedronate in postmenopausal osteoporosis: patient considerations with delayed-release formulation.
Journal: International journal of women's health 20120101
Title: Dasatinib as a bone-modifying agent: anabolic and anti-resorptive effects.
Journal: PloS one 20120101
Title: Idiopathic calcinosis cutis of nasal dorsum.
Journal: Journal of cutaneous and aesthetic surgery 20120101
Title: Osteoporosis in men.
Journal: Journal of osteoporosis 20120101
Title: Dietary pseudopurpurin improves bone geometry architecture and metabolism in red-bone Guishan goats.
Journal: PloS one 20120101
Title: Teriparatide - Indications beyond osteoporosis.
Journal: Indian journal of endocrinology and metabolism 20120101
Title: Osteonecrosis of jaw associated with bisphosphonate use.
Journal: Indian journal of endocrinology and metabolism 20120101
Title: Pathogenesis and bisphosphonate treatment of skeletal events and bone pain in metastatic cancer: focus on ibandronate.
Journal: Onkologie 20120101
Title: Ibandronate and cementless total hip arthroplasty: densitometric measurement of periprosthetic bone mass and new therapeutic approach to the prevention of aseptic loosening.
Journal: Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases 20120101
Title: [Polymers as excipients used in the technology of coated tablets containing ibandronic acid derivatives (bisphosphonates)].
Journal: Polimery w medycynie 20120101
Title: Active home-based cancer treatment.
Journal: Journal of multidisciplinary healthcare 20120101
Title: Phase II study of loading-dose ibandronate treatment in patients with breast cancer and bone metastases suffering from moderate to severe pain.
Journal: Onkologie 20120101
Title: Impact of long-term cinacalcet, ibandronate or teriparatide therapy on bone mineral density of hemodialysis patients: a pilot study.
Journal: American journal of nephrology 20120101
Title: Bisphosphonates for osteoporosis in primary biliary cirrhosis.
Journal: The Cochrane database of systematic reviews 20111207
Title: Cost-effectiveness of zoledronic acid in the prevention of skeletal-related events in patients with bone metastases secondary to advanced renal cell carcinoma: application to France, Germany, and the United Kingdom.
Journal: The European journal of health economics : HEPAC : health economics in prevention and care 20111201
Title: Daily or monthly ibandronate prevents or restores deteriorations of bone mass, architecture, biomechanical properties and markers of bone turnover in androgen-deficient aged rats.
Journal: The aging male : the official journal of the International Society for the Study of the Aging Male 20111201
Title: Zoledronate, ibandronate and clodronate enhance osteoblast differentiation in a dose dependent manner--a quantitative in vitro gene expression analysis of Dlx5, Runx2, OCN, MSX1 and MSX2.
Journal: Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 20111201
Title: Renal safety of ibandronate 6 mg infused over 15 min versus 60 min in breast cancer patients with bone metastases: a randomized open-label equivalence trial.
Journal: Breast (Edinburgh, Scotland) 20111201
Title: Effects of intravenous ibandronate injection on renal function in women with postmenopausal osteoporosis at high risk for renal disease--the DIVINE study.
Journal: Bone 20111201
Title: Monthly or weekly bisphosphonate? Evaluation of satisfaction in patients with postmenopausal osteoporosis using OPSAT-Q questionnaire during the BOOSTER study in Croatia.
Journal: Clinical rheumatology 20111201
Title: Impact of medication adherence on health care utilization and productivity: self-reported data from a cohort of postmenopausal women on osteoporosis therapy.
Journal: Clinical therapeutics 20111201
Title: Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Journal: PLoS computational biology 20111201
Title: Optimising the use of bone-targeted agents in patients with metastatic cancers: a practical guide for medical oncologists.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20111101
Title: Denosumab for the prevention of osteoporotic fractures in post-menopausal women: a NICE single technology appraisal.
Journal: PharmacoEconomics 20111101
Title: Integrated model for denosumab and ibandronate pharmacodynamics in postmenopausal women.
Journal: Biopharmaceutics & drug disposition 20111101
Title: Ask the doctor. I'm looking for information on Prolia and Reclast as alternatives to Boniva.
Journal: Harvard women's health watch 20111101
Title: The GISS trial: a phase II prevention trial of screening plus goserelin, ibandronate, versus screening alone in premenopausal women at increased risk of breast cancer.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20111001
Title: Analysis of the comparative effectiveness of 3 oral bisphosphonates in a large managed care organization: adherence, fracture rates, and all-cause cost.
Journal: Journal of managed care pharmacy : JMCP 20111001
Title: Effect of ibandronate on disseminated tumor cells in the bone marrow of patients with primary breast cancer: a pilot study.
Journal: Anticancer research 20111001
Title: Changes in renal function after different tandem hematopoietic stem-cell transplantation approaches in patients with multiple myeloma.
Journal: Journal of Korean medical science 20111001
Title: Benefit of infusions with ibandronate treatment in children with osteogenesis imperfecta.
Journal: Chinese medical journal 20111001
Title: Parenteral bisphosphonates for osteoporosis in patients with primary biliary cirrhosis.
Journal: American journal of therapeutics 20110901
Title: A comparative study of intravenous ibandronate and pamindronate in patients with bone metastases from breast or lung cancer: effect on metastatic bone pain.
Journal: American journal of therapeutics 20110901
Title: Osteopenia: a diagnostic and therapeutic challenge.
Journal: Current osteoporosis reports 20110901
Title: Efficacy and safety of monthly 150 mg oral ibandronate in women with postmenopausal osteoporosis: a systematic review and meta-analysis of randomized controlled trials.
Journal: The Korean journal of internal medicine 20110901
Title: High-resolution computed tomography for clinical imaging of bone microarchitecture.
Journal: Clinical orthopaedics and related research 20110801
Title: Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis.
Journal: Calcified tissue international 20110801
Title: Administration of sodium ibandronate in the treatment of complicated giant cell tumor of the spine.
Journal: Spine 20110801
Title: Non-surgical management of stage 3 biphosphonate-related oroantral fistula.
Journal: The British journal of oral & maxillofacial surgery 20110701
Title: Effect of bisphosphonates on anodized and heat-treated titanium surfaces: an animal experimental study.
Journal: Journal of periodontology 20110701
Title: The kidney and bisphosphonates.
Journal: Bone 20110701
Title: The relationship between the chemistry and biological activity of the bisphosphonates.
Journal: Bone 20110701
Title: [Assessment of volumetric bone mineral density and geometry for hip with clinical CT device].
Journal: Clinical calcium 20110701
Title: Effects of intravenous zoledronic acid and oral ibandronate on early changes in markers of bone turnover in patients with bone metastases from non-small cell lung cancer.
Journal: International journal of clinical oncology 20110601
Title: Advances in glucocorticoid-induced osteoporosis.
Journal: Current rheumatology reports 20110601
Title: New imaging modalities in bone.
Journal: Current rheumatology reports 20110601
Title: Intravenous bisphosphonates for post-menopausal osteoporosis: adherence to a network guideline.
Journal: Journal of clinical pharmacy and therapeutics 20110601
Title: Bisphosphonate-associated atypical fracture of the femur: Spontaneous healing with drug holiday and re-appearance after resumed drug therapy with bilateral simultaneous displaced fractures--a case report.
Journal: Acta orthopaedica 20110601
Title: Effects of D-003 (10 mg/day) on bone mineral density of the lumbar spine and femoral neck in postmenopausal women: a randomized, double-blinded study.
Journal: The Korean journal of internal medicine 20110601
Title: Intravenous ibandronate or sodium-fluoride--a 3.5 years study on bone density and fractures in Crohn's disease patients with osteoporosis.
Journal: Journal of gastrointestinal and liver diseases : JGLD 20110601
Title: Treatment of transient osteoporosis of the hip with intravenous zoledronate - a case report -.
Journal: Annals of rehabilitation medicine 20110601
Title: Commentary on an article by Jacob S. Vandermeer et al.: 'Local administration of ibandronate and bone morphogenetic protein-2 after ischemic osteonecrosis of the immature femoral head. A combined therapy that stimulates bone formation and decreases femoral head deformity'.
Journal: The Journal of bone and joint surgery. American volume 20110518
Title: Local administration of ibandronate and bone morphogenetic protein-2 after ischemic osteonecrosis of the immature femoral head: a combined therapy that stimulates bone formation and decreases femoral head deformity.
Journal: The Journal of bone and joint surgery. American volume 20110518
Title: Adherence and profile of non-persistence in patients treated for osteoporosis--a large-scale, long-term retrospective study in The Netherlands.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110501
Title: Ibandronate does not reduce the anabolic effects of PTH in ovariectomized rat tibiae: a microarchitectural and mechanical study.
Journal: Bone 20110501
Title: Low-magnitude high-frequency vibration (LMHFV) enhances bone remodeling in osteoporotic rat femoral fracture healing.
Journal: Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20110501
Title: Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110501
Title: Association of menopausal vasomotor symptoms with increased bone turnover during the menopausal transition.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110401
Title: Bisphosphonates for post-menopausal osteoporosis: are they all the same?
Journal: QJM : monthly journal of the Association of Physicians 20110401
Title: Association between atherosclerosis and osteoporosis, the role of vitamin D.
Journal: Archives of medical science : AMS 20110401
Title: Evidence of sustained vertebral and nonvertebral antifracture efficacy with ibandronate therapy: a systematic review.
Journal: Therapeutic advances in musculoskeletal disease 20110401
Title: Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110301
Title: Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro.
Journal: Oral diseases 20110301
Title: Bisphosphonates in phenytoin-induced bone disorder.
Journal: Bone 20110301
Title: Bone mineral disease in children after renal transplantation in steroid-free and steroid-treated patients--a prospective study.
Journal: Pediatric transplantation 20110301
Title: Azathioprine-induced fever in sarcoidosis.
Journal: The Annals of pharmacotherapy 20110301
Title: Treatment of lumbar pars interarticularis stress injuries in athletes with intravenous bisphosphonates: five case studies.
Journal: Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine 20110301
Title: The treatment of symptomatic osteoporotic spinal compression fractures.
Journal: The Journal of the American Academy of Orthopaedic Surgeons 20110301
Title: Prevalence, pathophysiology, screening and management of osteoporosis in gastric cancer patients.
Journal: Journal of gastric cancer 20110301
Title: Stability indicating ion chromatography method for the simultaneous determination of ibandronate sodium drug substance and its impurities.
Journal: Journal of pharmaceutical and biomedical analysis 20110220
Title: Molecular characterization of a novel geranylgeranyl pyrophosphate synthase from Plasmodium parasites.
Journal: The Journal of biological chemistry 20110204
Title: [Bisphosphonate treatment of osteoporosis and other skeletal diseases].
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20110204
Title: Osteonecrosis of the jaw and the role of macrophages.
Journal: Journal of the National Cancer Institute 20110202
Title: Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro.
Journal: Clinical oral investigations 20110201
Title: [Osteoporosis treatment with biphosphonates: Approaches to care reality].
Journal: Atencion primaria 20110201
Title: The efficacy of bisphosphonates in the prevention of vertebral, hip, and nonvertebral-nonhip fractures in osteoporosis: a network meta-analysis.
Journal: Seminars in arthritis and rheumatism 20110201
Title: Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110201
Title: Bisphosphonates inhibit phosphorylation of signal transducer and activator of transcription 3 and expression of suppressor of cytokine signaling 3: implications for their effects on innate immune function and osteoclastogenesis.
Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20110201
Title: Effects of ibandronate-hydroxyapatite on resorptive activity of osteoclasts.
Journal: Archives of medical science : AMS 20110201
Title: Bones and Crohn's: no benefit of adding sodium fluoride or ibandronate to calcium and vitamin D.
Journal: World journal of gastroenterology 20110121
Title: Ibandronate promotes osteogenic differentiation of periodontal ligament stem cells by regulating the expression of microRNAs.
Journal: Biochemical and biophysical research communications 20110107
Title: Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW).
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110101
Title: Differential effects of ibandronate, docetaxel and farnesol treatment alone and in combination on the growth of prostate cancer cell lines.
Journal: Acta oncologica (Stockholm, Sweden) 20110101
Title: Ibandronate affects bone growth and mineralization in rats with normal and reduced renal function.
Journal: Pediatric nephrology (Berlin, Germany) 20110101
Title: Computational insights into binding of bisphosphates to farnesyl pyrophosphate synthase.
Journal: Current medicinal chemistry 20110101
Title: Antifracture efficacy of currently available therapies for postmenopausal osteoporosis.
Journal: Drugs 20110101
Title: [Ibandronate].
Journal: Clinical calcium 20110101
Title: The association of adherence to osteoporosis therapies with fracture, all-cause medical costs, and all-cause hospitalizations: a retrospective claims analysis of female health plan enrollees with osteoporosis.
Journal: Journal of managed care pharmacy : JMCP 20110101
Title: When do bisphosphonates make the most sense?
Journal: The Journal of family practice 20110101
Title: The cost effectiveness of zoledronic acid 5 mg for the management of postmenopausal osteoporosis in women with prior fractures: evidence from Finland, Norway and the Netherlands.
Journal: Journal of medical economics 20110101
Title: Management of osteoporosis and associated quality of life in post menopausal women.
Journal: BMC musculoskeletal disorders 20110101
Title: [Effects of rat serum containing Chinese herbal medicine Sangen Decoction on osteoclastogenesis and bone resorption of osteoclasts induced by polymethylmethacrylate particles].
Journal: Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine 20110101
Title: (Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis.
Journal: Arthritis research & therapy 20110101
Title: The influence of bisphosphonates on human osteoblast migration and integrin aVb3/tenascin C gene expression in vitro.
Journal: Head & face medicine 20110101
Title: The role of i.v. ibandronate administration in osteoporosis therapy.
Journal: Endokrynologia Polska 20110101
Title: Updated recommendations for the diagnosis and management of osteoporosis: a local perspective.
Journal: Annals of Saudi medicine 20110101
Title: The facial skeleton in patients with osteoporosis: a field for disease signs and treatment complications.
Journal: Journal of osteoporosis 20110101
Title: Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management.
Journal: Breast cancer research : BCR 20110101
Title: Atrial fibrillation and the use of oral bisphosphonates.
Journal: Therapeutics and clinical risk management 20110101
Title: Fracture prevention in postmenopausal women.
Journal: BMJ clinical evidence 20110101
Title: Bisphosphonates can reduce bone hunger after parathyroidectomy in patients with primary hyperparathyroidism and osteitis fibrosa cystica.
Journal: Revista brasileira de reumatologia 20110101
Title: Role of zoledronic acid in the prevention and treatment of osteoporosis.
Journal: Clinical interventions in aging 20110101
Title: Bone health in patients with multiple sclerosis.
Journal: Journal of osteoporosis 20110101
Title: Zoledronic acid preserves bone structure and increases survival but does not limit tumour incidence in a prostate cancer bone metastasis model.
Journal: PloS one 20110101
Title: Emerging strategies and therapies for treatment of Paget's disease of bone.
Journal: Drug design, development and therapy 20110101
Title: Reporting characteristics of cancer pain: a systematic review and quantitative analysis of research publications in palliative care journals.
Journal: Indian journal of palliative care 20110101
Title: Association of Serum Phosphate and Related Factors in ESRD-Related Vascular Calcification.
Journal: International journal of nephrology 20110101
Title: If you don't take it - it can't work: the consequences of not being treated or nonadherence to osteoporosis therapy.
Journal: Therapeutics and clinical risk management 20110101
Title: Tiludronate treatment improves structural changes and symptoms of osteoarthritis in the canine anterior cruciate ligament model.
Journal: Arthritis research & therapy 20110101
Title: Adverse cutaneous drug reactions to ibandronate.
Journal: European journal of dermatology : EJD 20110101
Title: Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France.
Journal: BMC health services research 20110101
Title: [Regression of an osteolytic lesion in a patient with multiple myeloma treated with clodronate after a successful therapy with bortezomib-based regimen].
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 20110101
Title: Metastatic breast carcinoma in the mandible presenting as a periodontal abscess: a case report.
Journal: Journal of medical case reports 20110101
Title: Clinical utility of denosumab for treatment of bone loss in men and women.
Journal: Clinical interventions in aging 20110101
Title: Bone turnover is adequately suppressed in osteoporotic patients treated with bisphosphonates in daily practice.
Journal: BMC musculoskeletal disorders 20110101
Title: The evidence for efficacy of osteoporosis treatment in men with primary osteoporosis: a systematic review and meta-analysis of antiresorptive and anabolic treatment in men.
Journal: Journal of osteoporosis 20110101
Title: Orbital inflammatory disease in a patient treated with zoledronate.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20110101
Title: Increased human defensine levels hint at an inflammatory etiology of bisphosphonate-associated osteonecrosis of the jaw: an immunohistological study.
Journal: Journal of translational medicine 20110101
Title: Increased fracture rate in women with breast cancer: a review of the hidden risk.
Journal: BMC cancer 20110101
Title: Indian commentary on the 2009 KDIGO clinical practice guideline for the diagnosis, evaluation, and treatment of chronic kidney disease-mineral and bone disorders.
Journal: Indian journal of nephrology 20110101
Title: The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women.
Journal: BMC musculoskeletal disorders 20110101
Title: Effect of Cistanches Herba aqueous extract on bone loss in ovariectomized rat.
Journal: International journal of molecular sciences 20110101
Title: Tumour macrophages as potential targets of bisphosphonates.
Journal: Journal of translational medicine 20110101
Title: The role of galenic innovation in improving treatment compliance and persistence: three case studies.
Journal: ClinicoEconomics and outcomes research : CEOR 20110101
Title: Clinical utility of clodronate in the prevention and management of osteoporosis in patients intolerant of oral bisphosphonates.
Journal: Drug design, development and therapy 20110101
Title: [The role of i.v. ibandronate administration in osteoporosis therapy].
Journal: Endokrynologia Polska 20110101
Title: Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study.
Journal: BMJ (Clinical research ed.) 20110101
Title: Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy.
Journal: Clinical & developmental immunology 20110101
Title: Osteonecrosis of the jaws associated with the use of bisphosphonates. Discussion over 52 cases.
Journal: Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 20110101
Title: Biochemical bone turnover markers and osteoporosis in older men: where are we?
Journal: Journal of osteoporosis 20110101
Title: [Osteonecrosis of the jaw associated with oral treatment with ibandronate].
Journal: Anales del sistema sanitario de Navarra 20110101
Title: Osteopenia and osteoporosis in people living with HIV: multiprofessional approach.
Journal: HIV/AIDS (Auckland, N.Z.) 20110101
Title: Safety and tolerability of denosumab for the treatment of postmenopausal osteoporosis.
Journal: Drug, healthcare and patient safety 20110101
Title: Drug-drug interaction study between a novel oral ibandronate formulation and metformin.
Journal: Arzneimittel-Forschung 20110101
Title: How to manage postmenopausal osteoporosis?
Journal: Acta clinica Belgica 20110101
Title: Prospective clinical study of once monthly ibandronate in the treatment of osteoporosis and prevention of fractures in postmenopausal women: ORPHEUM Study.
Journal: Srpski arhiv za celokupno lekarstvo 20110101
Title: A randomized controlled trial to compare the efficacy of bisphosphonates in the management of painful bone metastasis.
Journal: Indian journal of palliative care 20110101
Title: Preventive effects of phytoestrogens against postmenopausal osteoporosis as compared to the available therapeutic choices: An overview.
Journal: Journal of natural science, biology, and medicine 20110101
Title: Adherence to bisphosphonate therapy in postmenopausal osteoporotic women.
Journal: Folia medica 20110101
Title: Osteoporosis and bisphosphonate-related osteonecrosis of the jaw bone.
Journal: ISRN rheumatology 20110101
Title: Ibandronate and periprosthetic bone mass: new therapeutic approach in periprosthetic loosening prevention.
Journal: Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases 20110101
Title: Preparation and properties of new co-crystals of ibandronate with gluco- or galactopyranoside derivatives.
Journal: Molecules (Basel, Switzerland) 20101208
Title: Cancer and renal insufficiency results of the BIRMA study.
Journal: British journal of cancer 20101207
Title: Compliance and persistence with osteoporosis medications: a critical review of the literature.
Journal: Reviews in endocrine & metabolic disorders 20101201
Title: Outcome of patients with early breast cancer receiving nitrogen-containing bisphosphonates: a comparative analysis from the Metropolitan Detroit Cancer Surveillance System.
Journal: Clinical breast cancer 20101201
Title: [Austrian guidance for the pharmacologic treatment of osteoporosis in postmenopausal women: Addendum 2010].
Journal: Wiener medizinische Wochenschrift (1946) 20101201
Title: Osteoporosis therapies: evidence from health-care databases and observational population studies.
Journal: Calcified tissue international 20101101
Title: Sustained vertebral antifracture efficacy of oral anti-osteoporotic therapies in postmenopausal osteoporosis.
Journal: Current medical research and opinion 20101101
Title: Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20101101
Title: Optimizing clinical benefits of bisphosphonates in cancer patients with bone metastases.
Journal: The oncologist 20101101
Title: Bilateral simultaneous femoral diaphyseal fractures in a patient with long-term ibandronate use.
Journal: Orthopedics 20101011
Title: Bone pain reduction in patients with metastatic breast cancer treated with ibandronate-results from a post-marketing surveillance study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20101001
Title: Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20101001
Title: Enzyme-linked immunosorbent serum assays (ELISAs) for rat and human N-terminal pro-peptide of collagen type I (PINP)--assessment of corresponding epitopes.
Journal: Clinical biochemistry 20101001
Title: Increases in hip and spine bone mineral density are predictive for vertebral antifracture efficacy with ibandronate.
Journal: Calcified tissue international 20101001
Title: Assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria.
Journal: British journal of cancer 20100907
Title: The increased expression of receptor activator of nuclear-kappaB ligand (RANKL) of multiple myeloma bone marrow stromal cells is inhibited by the bisphosphonate ibandronate.
Journal: Journal of cellular biochemistry 20100901
Title: Acute effects of intravenous administration of pamidronate in patients with osteoporosis.
Journal: Journal of Korean medical science 20100901
Title: [Bisphosphonates in adjuvant therapy of breast cancer].
Journal: Medizinische Klinik (Munich, Germany : 1983) 20100901
Title: Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100801
Title: [Antitumor properties of the bisphosphonate zoledronate and potential therapeutic implications in the clinic].
Journal: Bulletin du cancer 20100801
Title: Successful treatment of SAPHO syndrome with ibandronate.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20100801
Title: Diffuse skeletal pain after administration of alendronate.
Journal: Indian journal of pharmacology 20100801
Title: Treatment of osteoporosis after liver transplantation with ibandronate.
Journal: Transplant international : official journal of the European Society for Organ Transplantation 20100701
Title: Longitudinal change in clinical fracture incidence after initiation of bisphosphonates.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100601
Title: Regional distribution of spine and hip QCT BMD responses after one year of once-monthly ibandronate in postmenopausal osteoporosis.
Journal: Bone 20100601
Title: Effective dosage and administration schedule of oral alendronate for non-nociceptive symptoms in rats with chronic constriction injury.
Journal: Journal of Korean medical science 20100601
Title: Postmenopausal osteoporosis: another approach to management.
Journal: The Journal of family practice 20100601
Title: The neurological safety of epidural pamidronate in rats.
Journal: The Korean journal of pain 20100601
Title: Ibandronate and nonvertebral fracture efficacy: results of a recent pooled analysis.
Journal: The Physician and sportsmedicine 20100601
Title: [Monthly ibandronate attachment to Mexican and Chilean women with osteoporosis, with or without a biofeedback strategy].
Journal: Ginecologia y obstetricia de Mexico 20100601
Title: An in vitro assay to measure targeted drug delivery to bone mineral.
Journal: ChemMedChem 20100503
Title: Infusion of ibandronate once every 3 months effectively decreases bone resorption markers and increases bone mineral density in Chinese postmenopausal osteoporotic women: a 1-year study.
Journal: Journal of bone and mineral metabolism 20100501
Title: Age-dependence of femoral strength in white women and men.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100501
Title: Higher doses of bisphosphonates further improve bone mass, architecture, and strength but not the tissue material properties in aged rats.
Journal: Bone 20100501
Title: Patient preference and acceptability of calcium plus vitamin D3 supplementation: a randomised, open, cross-over trial.
Journal: Clinical rheumatology 20100501
Title: Absolute risk reduction in osteoporosis: assessing treatment efficacy by number needed to treat.
Journal: Rheumatology international 20100501
Title: A role for ethanol-induced oxidative stress in controlling lineage commitment of mesenchymal stromal cells through inhibition of Wnt/beta-catenin signaling.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100501
Title: Ibandronate does not increase risk of atrial fibrillation in analysis of pivotal clinical trials.
Journal: International journal of clinical practice 20100501
Title: How patients' lack of knowledge about oral bisphosphonates can interfere with medical and dental care.
Journal: Journal of the American Dental Association (1939) 20100501
Title: Efficacy and safety of monthly ibandronate in men with low bone density.
Journal: Bone 20100401
Title: Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs).
Journal: Bioorganic & medicinal chemistry 20100401
Title: Prescription of anti-osteoporosis drugs during 2004-2007-a nationwide register study in Norway.
Journal: European journal of clinical pharmacology 20100301
Title: Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: the DIVA study.
Journal: Bone 20100301
Title: Risk reduction of non-vertebral fractures with intravenous ibandronate: post-hoc analysis from DIVA.
Journal: Current medical research and opinion 20100301
Title: Renal function changes and NHS resource use in breast cancer patients with metastatic bone disease treated with IV zoledronic acid or oral ibandronic acid: a four-centre non-interventional study.
Journal: Journal of medical economics 20100301
Title: Review of the cardiovascular safety of zoledronic acid and other bisphosphonates for the treatment of osteoporosis.
Journal: Clinical therapeutics 20100301
Title: Assessment of fracture risk in women with breast cancer using current vs emerging guidelines.
Journal: British journal of cancer 20100216
Title: Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells.
Journal: Clinical oral investigations 20100201
Title: Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100201
Title: Oral ibandronate in metastatic bone breast cancer: the Florence University experience and a review of the literature.
Journal: Journal of chemotherapy (Florence, Italy) 20100201
Title: Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100101
Title: Management of symptomatic bone metastases from breast cancer with concomitant use of external radiotherapy and ibandronate: results of a prospective, pilot study.
Journal: The breast journal 20100101
Title: Phosphatase inhibitors with anti-angiogenic effect in vitro.
Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 20100101
Title: A novel 3-D mineralized tumor model to study breast cancer bone metastasis.
Journal: PloS one 20100101
Title: Bisphosphonates and risk of atrial fibrillation: a meta-analysis.
Journal: Arthritis research & therapy 20100101
Title: The utility of changes in serum levels of C-terminal telopeptide of type I collagen in predicting patient response to oral monthly ibandronate therapy.
Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20100101
Title: Evidence based guidelines for complex regional pain syndrome type 1.
Journal: BMC neurology 20100101
Title: Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial.
Journal: Breast cancer research : BCR 20100101
Title: Efficacy and safety of once monthly ibandronate treatment in patients with reduced bone mineral density--ESTHER study.
Journal: Srpski arhiv za celokupno lekarstvo 20100101
Title: Renal toxicity in patients with multiple myeloma receiving zoledronic acid vs. ibandronate: a retrospective medical records review.
Journal: Journal of cancer research and therapeutics 20100101
Title: Alterations in osteoclast function and phenotype induced by different inhibitors of bone resorption--implications for osteoclast quality.
Journal: BMC musculoskeletal disorders 20100101
Title: Managing bone mineral density with oral bisphosphonate therapy in women with breast cancer receiving adjuvant aromatase inhibition.
Journal: Breast cancer research : BCR 20100101
Title: Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients.
Journal: Head & face medicine 20100101
Title: The impact of bisphosphonates on the osteoblast proliferation and Collagen gene expression in vitro.
Journal: Head & face medicine 20100101
Title: Challenges in clinical patient management.
Journal: Cancer investigation 20100101
Title: Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.
Journal: Therapeutics and clinical risk management 20100101
Title: Development of clinical utility of zoledronic acid and patient considerations in the treatment of osteoporosis.
Journal: Patient preference and adherence 20100101
Title: Calcific uremic arteriolopathy: pathophysiology, reactive oxygen species and therapeutic approaches.
Journal: Oxidative medicine and cellular longevity 20100101
Title: Compliance and treatment satisfaction of post menopausal women treated for osteoporosis. Compliance with osteoporosis treatment.
Journal: BMC women's health 20100101
Title: Managing bone health in women with breast cancer under adjuvant treatment with aromatase inhibitors: pretreatment bone mineral density is important.
Journal: Breast cancer research : BCR 20100101
Title: Long-term renal safety profile of ibandronate 6 mg infused over 15 minutes.
Journal: Onkologie 20100101
Title: Health-related quality of life among patients with postmenopausal osteoporosis treated with weekly and monthly bisphosphonates.
Journal: Endocrine research 20100101
Title: Aging, human immunodeficiency virus, and bone health.
Journal: Clinical interventions in aging 20100101
Title: Genetic determinants of osteoporosis: common bases to cardiovascular diseases?
Journal: International journal of hypertension 20100101
Title: Fulminant staphylococcus lugdunensis septicaemia following a pelvic varicella-zoster virus infection in an immune-deficient patient: a case report.
Journal: European journal of medical research 20100101
Title: Impact of a multifaceted intervention to improve the clinical management of osteoporosis. The ESOSVAL-F study.
Journal: BMC health services research 20100101
Title: Ibandronate increases cortical bone density in patients with systemic lupus erythematosus on long-term glucocorticoid.
Journal: Arthritis research & therapy 20100101
Title: Calcaneal BMD Obtained by Dual X-Ray and Laser Predicts Future Hip Fractures-A Prospective Study on 4 398 Swedish Women.
Journal: Journal of osteoporosis 20100101
Title: Profile of teriparatide in the management of postmenopausal osteoporosis.
Journal: International journal of women's health 20100101
Title: Bisphosphonates in calcific aortic stenosis: association with slower progression in mild disease--a pilot retrospective study.
Journal: Cardiology 20100101
Title: Osteoprotective effects of Fructus Ligustri Lucidi aqueous extract in aged ovariectomized rats.
Journal: Chinese medicine 20100101
Title: The Brustkrebs-Studien.de website for breast cancer patients: User acceptance of a German internet portal offering information on the disease and treatment options, and a clinical trials matching service.
Journal: BMC cancer 20100101
Title: Administration of a tropomyosin receptor kinase inhibitor attenuates sarcoma-induced nerve sprouting, neuroma formation and bone cancer pain.
Journal: Molecular pain 20100101
Title: Zoledronic acid infusion for prevention and treatment of osteoporosis.
Journal: International journal of women's health 20100101
Title: Prevention of bone metastases and management of bone health in early breast cancer.
Journal: Breast cancer research : BCR 20100101
Title: Anti-tumour activity of bisphosphonates in preclinical models of breast cancer.
Journal: Breast cancer research : BCR 20100101
Title: Improving management of patients with advanced cancer.
Journal: Patient preference and adherence 20100101
Title: Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary.
Journal: Clinical interventions in aging 20100101
Title: The efficiency of Bonviva (Ibadronate) in women with pre-post menopause.
Journal: Medicinski arhiv 20100101
Title: Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphanates.
Journal: Prilozi 20100101
Title: Apoptosis-mediated cytotoxic effects of ibandronic acid on hormone- and drug-refractory prostate cancer cells and human breast cancer cells.
Journal: The Journal of international medical research 20100101
Title: Intravenous bisphosphonates for postmenopausal osteoporosis.
Journal: Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 20100101
Title: Management of glucocorticoid-induced osteoporosis: prevalence, and emerging treatment options.
Journal: Drug, healthcare and patient safety 20100101
Title: Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management.
Journal: Drug, healthcare and patient safety 20100101
Title: Pharmacoeconomic considerations in the treatment of breast cancer.
Journal: ClinicoEconomics and outcomes research : CEOR 20100101
Title: Spontaneous recanalization of complete internal carotid artery: a clinical reminder.
Journal: Journal of surgical technique and case report 20100101
Title: Efficacy of ibandronate: a long term confirmation.
Journal: Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases 20100101
Title: Metronomic administration of ibandronate and its anti-angiogenic effects in vitro.
Journal: Microvascular research 20091201
Title: Update on monthly oral bisphosphonate therapy for the treatment of osteoporosis: focus on ibandronate 150 mg and risedronate 150 mg.
Journal: Current medical research and opinion 20091201
Title: Osteoporosis management: a perspective based on bisphosphonate data from randomised clinical trials and observational databases.
Journal: International journal of clinical practice 20091201
Title: Review of osteoporosis pharmacotherapy for geriatric patients.
Journal: The American journal of geriatric pharmacotherapy 20091201
Title: Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091110
Title: Efficacy of ibandronate for the treatment of skeletal events in patients with metastatic breast cancer.
Journal: European journal of cancer care 20091101
Title: Comparison of monthly ibandronate versus weekly risedronate in preference, convenience, and bone turnover markers in Korean postmenopausal osteoporotic women.
Journal: Calcified tissue international 20091101
Title: A retrospective clinical and radiographic study on healing of periradicular lesions in patients taking oral bisphosphonates.
Journal: Journal of endodontics 20091101
Title: Ibadronate may prevent colorectal carcinogenesis in mice with ulcerative colitis.
Journal: Anticancer research 20091101
Title: Adjuvant bisphosphonates in endocrine-responsive breast cancer: what is their place in therapy?
Journal: Therapeutic advances in medical oncology 20091101
Title: Evaluation of the influence of the addition of biodegradable polymer matrices in the formulation of self-curing polymer systems for biomedical purposes.
Journal: Acta biomaterialia 20091001
Title: High-throughput HPLC-MS/MS method to determine ibandronate in human plasma for pharmacokinetic applications.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20091001
Title: [Anti-fracture efficacy of intravenous ibandronate: how to translate epidemiological studies into daily clinical practice].
Journal: Revue medicale de Liege 20091001
Title: Monthly ibandronate suppresses serum CTX-I within 3 days and maintains a monthly fluctuating pattern of suppression.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090901
Title: Ibandronate reduces endogenous reactive oxygen species levels in cultured prostate cancer and endothelial cells.
Journal: Microvascular research 20090901
Title: Ibandronate: a review of its vertebral and nonvertebral antifracture efficacy.
Journal: Women's health (London, England) 20090901
Title: Tolerability of dose escalation of ibandronate in patients with multiple myeloma and end-stage renal disease: a case series.
Journal: Onkologie 20090901
Title: [Emergencies in hematology and oncology].
Journal: Deutsche medizinische Wochenschrift (1946) 20090901
Title: [Diagnosis and treatment of bone marrow edema syndrome of the hip and differential diagnosis from avascular necrosis of femoral head].
Journal: Zhongguo gu shang = China journal of orthopaedics and traumatology 20090901
Title: Safety and antisorptive power of Ibandronate applied in the real-life setting.
Journal: Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20090901
Title: [The efficacy and safety of intravenous bisphosphonates in the treatment of primary hyperparathyroidism complicated by hypercalcemia crisis].
Journal: Zhonghua nei ke za zhi 20090901
Title: Impact of bone marker feedback on adherence to once monthly ibandronate for osteoporosis among Asian postmenopausal women.
Journal: International journal of rheumatic diseases 20090901
Title: Determination of rat vertebral bone compressive fatigue properties in untreated intact rats and zoledronic-acid-treated, ovariectomized rats.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090801
Title: Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090801
Title: Switching breast cancer patients with progressive bone metastases to third-generation bisphosphonates: measuring impact using the Functional Assessment of Cancer Therapy-Bone Pain.
Journal: Journal of pain and symptom management 20090801
Title: Osteonecrosis of the jaw and use of bisphosphonates in adjuvant breast cancer treatment: a meta-analysis.
Journal: Breast cancer research and treatment 20090801
Title: Prevention of vertebral fractures in osteoporosis: mixed treatment comparison of bisphosphonate therapies.
Journal: Current medical research and opinion 20090801
Title: Weekly versus monthly drug regimens: 1-year compliance and persistence with bisphosphonate therapy.
Journal: Current medical research and opinion 20090801
Title: Atraumatic bilateral femur fracture in long-term bisphosphonate use.
Journal: Orthopedics 20090801
Title: Pricey osteoporosis remedy doesn't beat older drugs.
Journal: Consumer reports 20090801
Title: Ibandronate prevents bone loss and reduces vertebral fracture risk in male cardiac transplant patients: a randomized double-blind, placebo-controlled trial.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090701
Title: The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090701
Title: Patient satisfaction in postmenopausal women treated with a weekly bisphosphonate transitioned to once-monthly ibandronate.
Journal: Journal of women's health (2002) 20090701
Title: Safety of adjuvant endocrine therapies in hormone receptor-positive early breast cancer.
Journal: Current oncology (Toronto, Ont.) 20090701
Title: Once-monthly oral ibandronate in postmenopausal osteoporosis: translation and updated review.
Journal: Clinical therapeutics 20090701
Title: Risk of renal impairment after treatment with ibandronate versus zoledronic acid: a retrospective medical records review.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20090601
Title: Risk of fracture in women treated with monthly oral ibandronate or weekly bisphosphonates: the eValuation of IBandronate Efficacy (VIBE) database fracture study.
Journal: Bone 20090501
Title: Improved GI tolerability with monthly ibandronate in women previously using weekly bisphosphonates.
Journal: Southern medical journal 20090501
Title: [Drugs under development for osteoporosis ].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20090501
Title: Evaluating the antifracture efficacy of bisphosphonates.
Journal: Reviews on recent clinical trials 20090501
Title: Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients.
Journal: Cancer 20090415
Title: Risk of severe gastrointestinal events in women treated with monthly ibandronate or weekly alendronate and risedronate.
Journal: The Annals of pharmacotherapy 20090401
Title: Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): additional results from the Monthly Oral Therapy With Ibandronate For Osteoporosis Intervention (MOTION) study.
Journal: Clinical therapeutics 20090401
Title: Efficacy and safety of monthly oral ibandronate in the prevention of postmenopausal bone loss.
Journal: Bone 20090301
Title: Preference for weekly and monthly bisphosphonates among patients with postmenopausal osteoporosis: results from the Croatian PROMO Study.
Journal: Clinical rheumatology 20090301
Title: Ibandronate dose response is associated with increases in bone mineral density and reductions in clinical fractures: results of a meta-analysis.
Journal: Bone 20090301
Title: The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats.
Journal: Biomaterials 20090301
Title: A sensitive post-column photochemical derivatization/fluorimetric detection system for HPLC determination of bisphosphonates.
Journal: Journal of chromatography. A 20090227
Title: Bisphosphonates and implants: an overview.
Journal: Acta orthopaedica 20090226
Title: Regular dental check-ups could be of benefit for patients receiving intravenous bisphosphonates. Regarding 'risks and benefits of bisphosphonates'.
Journal: British journal of cancer 20090224
Title: Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090201
Title: Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090201
Title: Plain film and CBCT findings in a case of bisphosphonate-related osteonecrosis of the jaw.
Journal: Quintessence international (Berlin, Germany : 1985) 20090201
Title: Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis.
Journal: The American journal of medicine 20090201
Title: Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents.
Journal: Cancer investigation 20090201
Title: [Osteoporosis].
Journal: Revue medicale suisse 20090114
Title: Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosis.
Journal: The Journal of clinical endocrinology and metabolism 20090101
Title: Oral ibandronate preserves trabecular microarchitecture: micro-computed tomography findings from the oral iBandronate Osteoporosis vertebral fracture trial in North America and Europe study.
Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20090101
Title: [New development in bisphosphonate treatment. Characteristics and effectiveness of intermittent bisphophonates].
Journal: Clinical calcium 20090101
Title: Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club.
Journal: International journal of clinical practice 20090101
Title: Zoledronic acid in metastatic chondrosarcoma and advanced sacrum chordoma: two case reports.
Journal: Journal of experimental & clinical cancer research : CR 20090101
Title: Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assay.
Journal: BMC cancer 20090101
Title: Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone.
Journal: Oncology 20090101
Title: Oral bisphosphonates and risk of atrial fibrillation and flutter in women: a self-controlled case-series safety analysis.
Journal: PloS one 20090101
Title: Preventing nonvertebral osteoporotic fractures with extended-interval bisphosphonates: regimen selection and clinical application.
Journal: Medscape journal of medicine 20090101
Title: Biphosphonates-related osteonecrosis of the jaw: Clinical and physiopathological considerations.
Journal: Therapeutics and clinical risk management 20090101
Title: Potential antitumor effects of nitrogen-containing bisphosphonate in hormone receptor negative breast cancer patients with bone metastases.
Journal: BMC cancer 20090101
Title: [Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women--update 2009].
Journal: Wiener medizinische Wochenschrift. Supplement 20090101
Title: Treatment of osteoporosis and prevention of new fractures: role of intravenously administered bisphosphonates.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20090101
Title: Diagnosis and management of osteoporosis in the older senior.
Journal: Clinical interventions in aging 20090101
Title: Once-yearly zoledronic acid in hip fracture prevention.
Journal: Clinical interventions in aging 20090101
Title: Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis.
Journal: Clinical interventions in aging 20090101
Title: Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture.
Journal: Therapeutics and clinical risk management 20090101
Title: Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data.
Journal: BMJ (Clinical research ed.) 20090101
Title: Bisphosphonate-associated adverse events.
Journal: Hormones (Athens, Greece) 20090101
Title: Treatment with intravenous pamidronate is a good alternative in case of gastrointestinal side effects or contraindications for oral bisphosphonates.
Journal: BMC musculoskeletal disorders 20090101
Title: Subchronic oral toxicity of salcaprozate sodium (SNAC) in Sprague-Dawley and Wistar rats.
Journal: International journal of toxicology 20090101
Title: Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital.
Journal: Drug safety 20090101
Title: Identification of secondary targets of N-containing bisphosphonates in mammalian cells via parallel competition analysis of the barcoded yeast deletion collection.
Journal: Genome biology 20090101
Title: Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies.
Journal: BMC musculoskeletal disorders 20090101
Title: Progress in osteoporosis and fracture prevention: focus on postmenopausal women.
Journal: Arthritis research & therapy 20090101
Title: Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment.
Journal: Clinical interventions in aging 20090101
Title: Hypercalcemia in a patient with cholangiocarcinoma: a case report.
Journal: International archives of medicine 20090101
Title: Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis.
Journal: Therapeutics and clinical risk management 20090101
Title: Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases.
Journal: Drug design, development and therapy 20090101
Title: Is there a role for ibandronate in the treatment of prostate cancer patients with bony metastases?
Journal: Acta oncologica (Stockholm, Sweden) 20090101
Title: Reducing hip fracture risk with risedronate in elderly women with established osteoporosis.
Journal: Clinical interventions in aging 20090101
Title: The evolving role of zoledronic acid in early breast cancer.
Journal: OncoTargets and therapy 20090101
Title: Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect.
Journal: Core evidence 20090101
Title: Lasofoxifene: Evidence of its therapeutic value in osteoporosis.
Journal: Core evidence 20090101
Title: Uterine C-Kit positive low grade stromal sarcoma.
Journal: Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 20090101
Title: Once-monthly risedronate for postmenopausal osteoporosis.
Journal: International journal of women's health 20090101
Title: Long-term safety and efficacy of raloxifene in the prevention and treatment of postmenopausal osteoporosis: an update.
Journal: International journal of women's health 20090101
Title: Treating postmenopausal osteoporosis in women at increased risk of fracture - critical appraisal of bazedoxifene: a review.
Journal: International journal of women's health 20090101
Title: Dendritic multishell architectures for drug and dye transport.
Journal: Journal of controlled release : official journal of the Controlled Release Society 20081218
Title: Oral versus intravenous ibandronic acid: a comparison of treatment options for metastatic bone disease.
Journal: Journal of cancer research and clinical oncology 20081201
Title: Bisphosphonate nephrotoxicity.
Journal: Kidney international 20081201
Title: Clinical and radiologic response in patients with bone metastases managed with combined radiotherapy and bisphosphonates.
Journal: Journal of surgical oncology 20081201
Title: Managing neoplastic bone disease with ibandronic acid: a preclinical and clinical data update.
Journal: Expert opinion on pharmacotherapy 20081201
Title: Optimizing dosing frequencies for bisphosphonates in the management of postmenopausal osteoporosis: patient considerations.
Journal: Clinical interventions in aging 20081201
Title: Aromatase inhibitors, efficacy and metabolic risk in the treatment of postmenopausal women with early breast cancer.
Journal: Clinical interventions in aging 20081201
Title: Denosumab: an investigational drug for the management of postmenopausal osteoporosis.
Journal: Biologics : targets & therapy 20081201
Title: Determination of bisphosphonate active pharmaceutical ingredients in pharmaceuticals and biological material: a review of analytical methods.
Journal: Journal of pharmaceutical and biomedical analysis 20081104
Title: [Bisphosphonates for osseus invasion caused by bronchial carcinoma].
Journal: Deutsche medizinische Wochenschrift (1946) 20081101
Title: Ibandronate: is there an effect on nonvertebral fractures?
Journal: Clinical rheumatology 20081001
Title: An open-label pilot trial of ibandronate for complex regional pain syndrome.
Journal: The Clinical journal of pain 20081001
Title: Recent developments in the management of postmenopausal osteoporosis with bisphosphonates: enhanced efficacy by enhanced compliance.
Journal: Journal of internal medicine 20081001
Title: Prevention of anastrozole-induced bone loss with monthly oral ibandronate during adjuvant aromatase inhibitor therapy for breast cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20081001
Title: A rapid histological score for the semiquantitative assessment of bone metastases in experimental models of breast cancer.
Journal: Onkologie 20081001
Title: [Ibandronate in the treatment of postmenopausal osteoporosis].
Journal: Lege artis medicinae : uj magyar orvosi hirmondo 20081001
Title: Inhibition of geranylgeranyl diphosphate synthase by bisphosphonates: a crystallographic and computational investigation.
Journal: Journal of medicinal chemistry 20080925
Title: Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.
Journal: Oral oncology 20080901
Title: Intravenous ibandronate rapidly reduces pain, neurochemical indices of central sensitization, tumor burden, and skeletal destruction in a mouse model of bone cancer.
Journal: Journal of pain and symptom management 20080901
Title: New automated multiplex assay for bone turnover markers in osteoporosis.
Journal: Clinical chemistry 20080901
Title: Oral nitrogen-containing bisphosphonates: a systematic review of randomized clinical trials and vertebral fractures.
Journal: Current medical research and opinion 20080901
Title: Acute phase reaction with intravenous ibandronate.
Journal: The American journal of medicine 20080901
Title: Nonvertebral fracture risk reduction with nitrogen-containing bisphosphonates.
Journal: Current osteoporosis reports 20080901
Title: Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations.
Journal: The American journal of managed care 20080901
Title: [Update on treatment of postmenopausal osteoporosis].
Journal: Revue medicale de Bruxelles 20080901
Title: Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women.
Journal: Clinical interventions in aging 20080901
Title: Monthly oral ibandronate is effective and well tolerated after 3 years: the MOBILE long-term extension.
Journal: Clinical rheumatology 20080801
Title: [Daily practice using the guidelines for prevention and treatment of osteoporosis. Evolution of bisphosphonate therapy. Intravenous injection].
Journal: Clinical calcium 20080801
Title: The use of calcium and vitamin D in the management of osteoporosis.
Journal: Therapeutics and clinical risk management 20080801
Title: The diagnosis and treatment of primary osteoporosis according to current guidelines.
Journal: Deutsches Arzteblatt international 20080801
Title: Bisphosphonate coating on titanium screws increases mechanical fixation in rat tibia after two weeks.
Journal: Journal of biomedical materials research. Part A 20080701
Title: Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20080701
Title: Rab proteins and Rab-associated proteins: major actors in the mechanism of protein-trafficking disorders.
Journal: European journal of pediatrics 20080701
Title: Identification of novel bone-specific molecular targets of binge alcohol and ibandronate by transcriptome analysis.
Journal: Alcoholism, clinical and experimental research 20080701
Title: Oral osteonecrosis associated with the use of ibandronate: report of a case and clinical implications.
Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20080701
Title: Ibandronate in profile: drug characteristics and clinical efficacy.
Journal: Expert opinion on drug metabolism & toxicology 20080701
Title: Risks and benefits of bisphosphonates.
Journal: British journal of cancer 20080603
Title: Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080601
Title: Preclinical evidence for nitrogen-containing bisphosphonate inhibition of farnesyl diphosphate (FPP) synthase in the kidney: implications for renal safety.
Journal: Toxicology in vitro : an international journal published in association with BIBRA 20080601
Title: Changes in bone remodelling and antifracture efficacy of intermittent bisphosphonate therapy: implications from clinical studies with ibandronate.
Journal: Postgraduate medical journal 20080601
Title: Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis.
Journal: Clinical interventions in aging 20080601
Title: Bisphosphonates in the management of postmenopausal osteoporosis--optimizing efficacy in clinical practice.
Journal: Clinical interventions in aging 20080601
Title: Clinical challenges in the management of osteoporosis.
Journal: Clinical interventions in aging 20080601
Title: Treatment preference for monthly oral ibandronate and weekly oral alendronate in women with postmenopausal osteoporosis: A randomized, crossover study (BALTO II).
Journal: Joint, bone, spine : revue du rhumatisme 20080501
Title: Osteochemonecrosis of the jaws due to bisphosphonate treatments. Update.
Journal: Medicina oral, patologia oral y cirugia bucal 20080501
Title: Ibandronate in benign bone disease.
Journal: Reviews on recent clinical trials 20080501
Title: Quarterly intravenous ibandronate for postmenopausal osteoporosis.
Journal: Women's health (London, England) 20080501
Title: Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase.
Journal: Journal of medicinal chemistry 20080410
Title: Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain.
Journal: European journal of pain (London, England) 20080401
Title: European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080401
Title: 3-year results of a member and physician intervention to reduce risk associated with glucocorticoid-induced osteoporosis in a health plan.
Journal: Journal of managed care pharmacy : JMCP 20080401
Title: Adherence to and gastrointestinal tolerability of monthly oral or quarterly intravenous ibandronate therapy in women with previous intolerance to oral bisphosphonates: a 12-month, open-label, prospective evaluation.
Journal: Clinical therapeutics 20080401
Title: Use of ibandronate in the prevention of skeletal events in metastatic breast cancer.
Journal: Therapeutics and clinical risk management 20080401
Title: A Phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy.
Journal: Breast cancer research and treatment 20080301
Title: Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapies.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080301
Title: Cost-effectiveness of a fixed dose combination of alendronate and cholecalciferol in the treatment and prevention of osteoporosis in the United Kingdom and The Netherlands.
Journal: Current medical research and opinion 20080301
Title: Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study.
Journal: The Journal of rheumatology 20080301
Title: [Osteonecrosis of the jaw developing during bisphosphonate treatment].
Journal: Magyar onkologia 20080301
Title: Significance of a decline in bone mineral density while receiving oral bisphosphonate treatment.
Journal: Clinical therapeutics 20080301
Title: Intravenous zoledronic acid for the treatment of osteoporosis.
Journal: Current osteoporosis reports 20080301
Title: Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis.
Journal: Annals of internal medicine 20080205
Title: Reply to the article 'oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases' by J.-J. Body et al. (Ann Oncol 2007; 18: 1165-1171).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20080201
Title: Ibandronic acid IV: new formulation. Unconvincing evidence.
Journal: Prescrire international 20080201
Title: Ibandronic acid: new drug. Osteoporosis: one tablet a month, but risk of a 'flu-like' syndrome.
Journal: Prescrire international 20080201
Title: Zoledronic acid in the management of metastatic bone disease.
Journal: Therapeutics and clinical risk management 20080201
Title: [Prescription of bisphosphonates in prostate cancer].
Journal: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20080201
Title: Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080101
Title: Non-vertebral fracture risk reduction with oral bisphosphonates: challenges with interpreting clinical trial data.
Journal: Current medical research and opinion 20080101
Title: Once-monthly oral ibandronate compared with weekly oral alendronate in postmenopausal osteoporosis: results from the head-to-head MOTION study.
Journal: Current medical research and opinion 20080101
Title: Ibandronate and the risk of non-vertebral and clinical fractures in women with postmenopausal osteoporosis: results of a meta-analysis of phase III studies.
Journal: Current medical research and opinion 20080101
Title: Vertebral fracture diagnosis in the multinational BONE study of oral ibandronate: quality management in radiology.
Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20080101
Title: Extracellular calcium increases bisphosphonate-induced growth inhibition of breast cancer cells.
Journal: Breast cancer research : BCR 20080101
Title: Induction of calcification by serum depletion in cell culture: a model for focal calcification in aortas related to atherosclerosis.
Journal: Lipids in health and disease 20080101
Title: Going beyond efficacy: strategies for cancer pain management.
Journal: Current oncology (Toronto, Ont.) 20080101
Title: A primer of bone metastases management in breast cancer patients.
Journal: Current oncology (Toronto, Ont.) 20080101
Title: Zoledronic acid: a pharmacoeconomic review of its use in the management of bone metastases.
Journal: PharmacoEconomics 20080101
Title: Medical treatment of malignancy-associated hypercalcemia.
Journal: Current medicinal chemistry 20080101
Title: Cost effectiveness of ibandronate for the prevention of fractures in inflammatory bowel disease-related osteoporosis: cost-utility analysis using a Markov model.
Journal: PharmacoEconomics 20080101
Title: Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice.
Journal: BMC cancer 20080101
Title: [Cost-effectiveness of oral ibandronate, i.v. zoledronic acid and i.v. generic pamidronate in the management of metastatic bone disease in breast cancer patients: two parallel studies].
Journal: Recenti progressi in medicina 20080101
Title: Rapid suppression of bone resorption marker levels with ibandronate therapy in a bisphosphonate-naïve population.
Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20080101
Title: Cost-effectiveness of oral clodronate compared with oral ibandronate, intravenous zoledronate or intravenous pamidronate in breast cancer patients.
Journal: The Journal of international medical research 20080101
Title: Choline-stabilized orthosilicic acid supplementation as an adjunct to calcium/vitamin D3 stimulates markers of bone formation in osteopenic females: a randomized, placebo-controlled trial.
Journal: BMC musculoskeletal disorders 20080101
Title: Renal toxicity following zoledronic acid reversed with ibandronate in a prostate cancer patient with bone metastases.
Journal: Urologia internationalis 20080101
Title: Ibandronate uptake in the jaw is similar to long bones and vertebrae in the rat.
Journal: Journal of bone and mineral metabolism 20080101
Title: Treatment of reduced bone density with ibandronate in dialysis patients.
Journal: Journal of nephrology 20080101
Title: [Non-hormonal treatments of postmenopausal osteoporosis].
Journal: Gynecologie, obstetrique & fertilite 20080101
Title: Preclinical and clinical efficacy of the bisphosphonate ibandronate in cancer treatment.
Journal: Current clinical pharmacology 20080101
Title: Mediastinal plasmacytoma with multiple myeloma presenting as a diagnostic dilemma.
Journal: Cases journal 20080101
Title: Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007.
Journal: Journal of experimental & clinical cancer research : CR 20080101
Title: Novel therapies in breast cancer: what is new from ASCO 2008.
Journal: Journal of hematology & oncology 20080101
Title: Induction of apoptosis of human primary osteoclasts treated with extracts from the medicinal plant Emblica officinalis.
Journal: BMC complementary and alternative medicine 20080101
Title: Osteoclasts are active in bone forming metastases of prostate cancer patients.
Journal: PloS one 20080101
Title: Osteonecrosis of the jaw in a patient treated with ibandronate.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20080101
Title: [Hypercalcaemic crisis and acute renal failure due to primary hyperparathyroidism].
Journal: Deutsche medizinische Wochenschrift (1946) 20080101
Title: Ibandronate: a review of its use in the management of postmenopausal osteoporosis.
Journal: Drugs 20080101
Title: Characteristics of patients initiating raloxifene compared to those initiating bisphosphonates.
Journal: BMC women's health 20080101
Title: Renal tolerability of intermittent intravenous ibandronate treatment for patients with postmenopausal osteoporosis: a review.
Journal: Clinical and experimental rheumatology 20080101
Title: Quality of life measurement in bone metastases: A literature review.
Journal: Journal of pain research 20080101
Title: Metastatic ductal eccrine adenocarcinoma masquerading as an invasive ductal carcinoma of the male breast.
Journal: Journal of cutaneous pathology 20071201
Title: Evidence based medicine and effective interventions of pharmacological therapy for the prevention of osteoporotic fractures.
Journal: Minerva endocrinologica 20071201
Title: Teriparatide in the management of osteoporosis.
Journal: Clinical interventions in aging 20071201
Title: Osteoporosis in the aging male: treatment options.
Journal: Clinical interventions in aging 20071201
Title: Local peroperative treatment with a bisphosphonate improves the fixation of total knee prostheses: a randomized, double-blind radiostereometric study of 50 patients.
Journal: Acta orthopaedica 20071201
Title: Linköping University Medical Dissertation No. 1033. Following the mevalonate pathway to bone heal alley.
Journal: Acta orthopaedica. Supplementum 20071201
Title: [New bone density conservation agents for osteoporosis under research and development: Ibandronate].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20071128
Title: Ibandronate is effective in preventing skeletal events in patients with bone metastases from colorectal cancer.
Journal: European journal of cancer care 20071101
Title: Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis--usefulness of alendronate and risedronate.
Journal: Expert opinion on pharmacotherapy 20071101
Title: Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates.
Journal: Journal of dental research 20071101
Title: Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
Journal: Annals of the New York Academy of Sciences 20071101
Title: Progression of efficacy with ibandronate: a paradigm for the development of new bisphosphonates.
Journal: Annals of the New York Academy of Sciences 20071101
Title: [Mandible osteonechrosis associated to bisfosfonates].
Journal: Ginecologia y obstetricia de Mexico 20071101
Title: Injectable bisphosphonates for the treatment of osteoporosis.
Journal: Women's health (London, England) 20071101
Title: Vitamin D and ibandronate prevent cancellous bone loss associated with binge alcohol treatment in male rats.
Journal: Bone 20071001
Title: Osteoporosis: non-hormonal treatment.
Journal: Climacteric : the journal of the International Menopause Society 20071001
Title: [The benefit from ibandronate in the treatment of postmenopausal osteoporosis].
Journal: Vnitrni lekarstvi 20071001
Title: Use of zoledronic acid in the treatment of Paget's disease.
Journal: Therapeutics and clinical risk management 20071001
Title: Application of metabonomics in a comparative profiling study reveals N-acetylfelinine excretion as a biomarker for inhibition of the farnesyl pathway by bisphosphonates.
Journal: Chemical research in toxicology 20070901
Title: Osteoporosis medication profile preference: results from the PREFER-US study.
Journal: Health expectations : an international journal of public participation in health care and health policy 20070901
Title: Persistence across weekly and monthly bisphosphonates: analysis of US retail pharmacy prescription refills.
Journal: Current medical research and opinion 20070901
Title: [Adjuvant therapy of locally advanced prostate carcinoma with ibandronate].
Journal: Der Urologe. Ausg. A 20070901
Title: Update on osteoporosis management in long-term care: focus on bisphosphonates.
Journal: Journal of the American Medical Directors Association 20070901
Title: Update on bazedoxifene: a novel selective estrogen receptor modulator.
Journal: Clinical interventions in aging 20070901
Title: Fracture prevention in postmenopausal women.
Journal: BMJ clinical evidence 20070901
Title: Renal safety and pharmacokinetics of ibandronate in multiple myeloma patients with or without impaired renal function.
Journal: Journal of clinical pharmacology 20070801
Title: A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Journal: Clinical therapeutics 20070801
Title: Oral bisphosphonate associated osteonecrosis of the jaws: three case reports.
Journal: British dental journal 20070728
Title: Changes in bone remodelling and antifracture efficacy of intermittent bisphosphonate therapy: implications from clinical studies with ibandronate.
Journal: Annals of the rheumatic diseases 20070701
Title: Oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20070701
Title: Is cortical bone hip? What determines cortical bone properties?
Journal: Bone 20070701
Title: New and emerging treatments for osteoporosis.
Journal: Current opinion in rheumatology 20070701
Title: Pharmacological treatment of osteoporosis for people over 70.
Journal: Aging clinical and experimental research 20070601
Title: Clinical evaluation of novel bisphosphonate dosing regimens in osteoporosis: the role of comparative studies and implications for future studies.
Journal: Clinical therapeutics 20070601
Title: Validation of a capillary electrophoresis method for the analysis of ibandronate related impurities.
Journal: Journal of pharmaceutical and biomedical analysis 20070509
Title: Therapeutic adherence to bisphosphonates.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20070501
Title: Bisphosphonates. A cornerstone of osteoporosis treatment.
Journal: Mayo Clinic women's healthsource 20070501
Title: [Nurse's role in the home management of patients with breast cancer and bone metastases].
Journal: Soins; la revue de reference infirmiere 20070501
Title: Advances in the management of corticosteroid-induced osteoporosis with bisphosphonates.
Journal: Clinical rheumatology 20070401
Title: Managing metastatic bone pain: the role of bisphosphonates.
Journal: Journal of pain and symptom management 20070401
Title: Ibandronate injections in postmenopausal women with osteoporosis.
Journal: Current rheumatology reports 20070401
Title: Ibandronate treatment reverses glucocorticoid-induced loss of bone mineral density and strength in minipigs.
Journal: Bone 20070301
Title: International Society of Geriatric Oncology (SIOG) clinical practice recommendations for the use of bisphosphonates in elderly patients.
Journal: European journal of cancer (Oxford, England : 1990) 20070301
Title: Use of intravenous bisphosphonates in osteoporosis.
Journal: Current osteoporosis reports 20070301
Title: Prevention and treatment of glucocorticoid-induced osteoporosis.
Journal: Current osteoporosis reports 20070301
Title: Bisphosphonates: mode of action and pharmacology.
Journal: Pediatrics 20070301
Title: The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis.
Journal: Clinical interventions in aging 20070301
Title: Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal women.
Journal: Clinical interventions in aging 20070301
Title: Differential effects of bisphosphonates on breast cancer cell lines.
Journal: Cancer letters 20070208
Title: Effects of ibandronate on bone quality: preclinical studies.
Journal: Bone 20070201
Title: Inhibition of bone resorption, rather than direct cytotoxicity, mediates the anti-tumour actions of ibandronate and osteoprotegerin in a murine model of breast cancer bone metastasis.
Journal: Bone 20070201
Title: Drug approvals.
Journal: The Nurse practitioner 20070201
Title: Osteoporosis: strategies for prevention and management.
Journal: Best practice & research. Clinical rheumatology 20070201
Title: [Osteoporosis treatment].
Journal: Revue medicale suisse 20070117
Title: Combination ibandronate and radiotherapy for the treatment of bone metastases: clinical evaluation and radiologic assessment.
Journal: International journal of radiation oncology, biology, physics 20070101
Title: Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20070101
Title: Retention, distribution, and effects of intraosseously administered ibandronate in the infarcted femoral head.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20070101
Title: [Therapeutic agents for disorders of bone and calcium metabolism: Ibandronate].
Journal: Clinical calcium 20070101
Title: The bisphosphonate ibandronate accelerates osseointegration of hydroxyapatite-coated cementless implants in an animal model.
Journal: Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20070101
Title: Preventative ibandronate treatment has the most beneficial effect on the microstructure of bone in experimental tumor osteolysis.
Journal: Journal of bone and mineral metabolism 20070101
Title: The Interleukin-6 inflammation pathway from cholesterol to aging--role of statins, bisphosphonates and plant polyphenols in aging and age-related diseases.
Journal: Immunity & ageing : I & A 20070101
Title: Impact of cytokines and T lymphocytes upon osteoclast differentiation and function.
Journal: Arthritis research & therapy 20070101
Title: Clinical usefulness of bisphosphonates in oncology: treatment of bone metastases, antitumoral activity and effect on bone resorption markers.
Journal: The International journal of biological markers 20070101
Title: A novel study investigating the therapeutic outcome of patients with lytic, mixed and sclerotic bone metastases treated with combined radiotherapy and ibandronate.
Journal: Clinical & experimental metastasis 20070101
Title: Intermittent bisphosphonate therapy in postmenopausal osteoporosis: progress to date.
Journal: Drugs & aging 20070101
Title: Breast cancer metastasis to the stomach may mimic primary gastric cancer: report of two cases and review of literature.
Journal: World journal of surgical oncology 20070101
Title: Multiple myeloma/hypercalcemia.
Journal: Arthritis research & therapy 20070101
Title: Host-derived RANKL is responsible for osteolysis in a C4-2 human prostate cancer xenograft model of experimental bone metastases.
Journal: BMC cancer 20070101
Title: Safety considerations with bisphosphonates for the treatment of osteoporosis.
Journal: Drug safety 20070101
Title: [Advances in the treatment of postmenopausal osteoporosis].
Journal: Revue medicale de Liege 20070101
Title: The association between compliance and persistence with bisphosphonate therapy and fracture risk: a review.
Journal: BMC musculoskeletal disorders 20070101
Title: Randomised controlled trials for evaluating the prescribing impact of information meetings led by pharmacists and of new information formats, in General Practice in Italy.
Journal: BMC health services research 20070101
Title: The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: a structured review of the literature.
Journal: PharmacoEconomics 20070101
Title: A review of bone pain relief with ibandronate and other bisphosphonates in disorders of increased bone turnover.
Journal: Clinical and experimental rheumatology 20070101
Title: Adverse effects of bisphosphonates: current issues.
Journal: The journal of supportive oncology 20070101
Title: The immune response is involved in atherosclerotic plaque calcification: could the RANKL/RANK/OPG system be a marker of plaque instability?
Journal: Clinical & developmental immunology 20070101
Title: [Does ibandronate (Bonviva) have an impact on non-vertebral fractures?].
Journal: Reumatizam 20070101
Title: Treatment of bone metastases and bone pain with bisphosphonates.
Journal: Supportive cancer therapy 20070101
Title: Isoprenoid biosynthesis as a drug target: bisphosphonate inhibition of Escherichia coli K12 growth and synergistic effects of fosmidomycin.
Journal: Journal of medicinal chemistry 20061214
Title: Drug insight: Existing and emerging therapies for osteoporosis.
Journal: Nature clinical practice. Endocrinology & metabolism 20061201
Title: Population pharmacokinetics of ibandronate in Caucasian and Japanese healthy males and postmenopausal females.
Journal: International journal of clinical pharmacology and therapeutics 20061201
Title: Patient preference and adherence: comparative US studies between two bisphosphonates, weekly risedronate and monthly ibandronate.
Journal: Current medical research and opinion 20061201
Title: Bisphosphonates.
Journal: Annals of the New York Academy of Sciences 20061201
Title: Strontium ranelate: a novel treatment for postmenopausal osteoporosis: a review of safety and efficacy.
Journal: Clinical interventions in aging 20061201
Title: Comparative effects of antiresorptive agents on bone mineral density and bone turnover in postmenopausal women.
Journal: Clinical interventions in aging 20061201
Title: Patient preference in the management of postmenopausal osteoporosis with bisphosphonates.
Journal: Clinical interventions in aging 20061201
Title: Compliance with treatment for osteoporosis.
Journal: Lancet (London, England) 20061111
Title: Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate.
Journal: Kidney international 20061101
Title: Hip and non-spine fracture risk reductions differ among antiresorptive agents: Evidence from randomised controlled trials.
Journal: International journal of clinical practice 20061101
Title: Bisphosphonates prevent experimental vascular calcification: Treat the bone to cure the vessels?
Journal: Kidney international 20061101
Title: Differences in nephrotoxicity of intravenous bisphosphonates for the treatment of malignancy-related bone disease.
Journal: Onkologie 20061101
Title: [Ibandronate (Bonviva) in the treatment of postmenopausal osteoporosis].
Journal: Revue medicale de Liege 20061101
Title: Breast cancer: bisphosphonate therapy for metastatic bone disease.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20061015
Title: Oral bisphosphonates as adjuvant therapy for operable breast cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20061015
Title: Ibandronate (boniva) offers new options for osteoporosis.
Journal: The Nurse practitioner 20061001
Title: Clinical utility of a pharmacostatistical model for ibandronate in postmenopausal osteoporosis.
Journal: Current drug metabolism 20061001
Title: [The osteoporosis patient with renal insufficiency: what has to be taken into account in the selection and administration of antiosteoporosis medication?].
Journal: Zeitschrift fur Rheumatologie 20060901
Title: Parathyromatosis and the challenge of treatment.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20060901
Title: [DVO guideline 2006. What changes have there been in the diagnosis, prevention and treatment of osteoporosis?].
Journal: Zeitschrift fur Rheumatologie 20060901
Title: Management of age-related osteoporosis and prevention of associated fractures.
Journal: Therapeutics and clinical risk management 20060901
Title: New options of pharmacological treatment of osteoporosis.
Journal: Ortopedia, traumatologia, rehabilitacja 20060831
Title: Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study.
Journal: International journal of clinical practice 20060801
Title: Developments in the pharmacotherapeutic management of osteoporosis.
Journal: Expert opinion on pharmacotherapy 20060801
Title: Rinsing morcellised bone grafts with bisphosphonate solution prevents their resorption. A prospective randomised double-blinded study.
Journal: The Journal of bone and joint surgery. British volume 20060801
Title: New drugs 06, part II.
Journal: Nursing 20060801
Title: Intravenous ibandronate (Boniva).
Journal: The Medical letter on drugs and therapeutics 20060801
Title: Aromatase inhibitors and bone loss.
Journal: Oncology (Williston Park, N.Y.) 20060801
Title: Local bioavailability and distribution of systemically (parenterally) administered ibandronate in the infarcted femoral head.
Journal: Bone 20060701
Title: Bone marker response in chronic diffuse sclerosing osteomyelitis treated with intravenous ibandronate.
Journal: Annals of the rheumatic diseases 20060701
Title: Intravenous ibandronate does not affect time to renal function deterioration in patients with skeletal metastases from breast cancer: phase III trial results.
Journal: European journal of cancer care 20060701
Title: Prescription drug therapies for prevention and treatment of postmenopausal osteoporosis.
Journal: Journal of managed care pharmacy : JMCP 20060701
Title: Osseointegration of cementless implants with different bisphosphonate regimens.
Journal: Clinical orthopaedics and related research 20060601
Title: Management of the adverse effects associated with intravenous bisphosphonates.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20060601
Title: Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study.
Journal: Arthritis and rheumatism 20060601
Title: How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy.
Journal: The Annals of pharmacotherapy 20060601
Title: Less frequent dosing of bisphosphonates in osteoporosis: focus on ibandronate.
Journal: Current medical research and opinion 20060601
Title: Fracture prevention in postmenopausal women.
Journal: Clinical evidence 20060601
Title: Postmenopausal osteoporosis. What have we learned since the introduction of bisphosphonates?
Journal: Reviews in endocrine & metabolic disorders 20060601
Title: Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.
Journal: Bone 20060501
Title: Relative binding affinities of bisphosphonates for human bone and relationship to antiresorptive efficacy.
Journal: Bone 20060501
Title: Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study.
Journal: Annals of the rheumatic diseases 20060501
Title: Bisphosphonates for malignancy-related bone disease: current status, future developments.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20060501
Title: Extracellular matrix changes in knee joint cartilage following bone-active drug treatment.
Journal: Cell and tissue research 20060501
Title: Ibandronate, an experimental intravenous bisphosphonate for osteoporosis, bone metastases, and hypercalcemia of malignancy.
Journal: Pharmacotherapy 20060501
Title: Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
Journal: Current medical research and opinion 20060501
Title: What's new in clinical pharmacology and therapeutics.
Journal: WMJ : official publication of the State Medical Society of Wisconsin 20060501
Title: Ibandronate: once-monthly and intravenous dosing options for osteoporosis treatment.
Journal: Women's health (London, England) 20060501
Title: Oral ibandronate in the management of postmenopausal osteoporosis: review of upper gastrointestinal safety.
Journal: Maturitas 20060420
Title: Alendronate in bone cement: fatigue life degraded by liquid, not by powder.
Journal: Clinical orthopaedics and related research 20060401
Title: Adherence, patient preference and dosing frequency: understanding the relationship.
Journal: Bone 20060401
Title: Beyond daily dosing: clinical experience.
Journal: Bone 20060401
Title: Ibandronate: pharmacology and preclinical studies.
Journal: Bone 20060401
Title: Once-monthly dosing: an effective step forward.
Journal: Bone 20060401
Title: Improving compliance and persistence with bisphosphonate therapy for osteoporosis.
Journal: The American journal of medicine 20060401
Title: Preventing osteoporosis-related fractures: an overview.
Journal: The American journal of medicine 20060401
Title: Injectable drug approved for osteoporosis.
Journal: Health news (Waltham, Mass.) 20060401
Title: Practical considerations of new drugs: new choices for old problems.
Journal: The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20060401
Title: Once-monthly ibandronate for postmenopausal osteoporosis: review of a new dosing regimen.
Journal: Clinical therapeutics 20060401
Title: Bisphosphonates: from bench to bedside.
Journal: Annals of the New York Academy of Sciences 20060401
Title: Modeling of serum C-telopeptide levels with daily and monthly oral ibandronate in humans.
Journal: Annals of the New York Academy of Sciences 20060401
Title: Drug insight: Bisphosphonates for postmenopausal osteoporosis.
Journal: Nature clinical practice. Endocrinology & metabolism 20060401
Title: Role of bisphosphonates for the management of skeletal complications and bone pain from skeletal metastases.
Journal: Supportive cancer therapy 20060401
Title: Enthalpy versus entropy-driven binding of bisphosphonates to farnesyl diphosphate synthase.
Journal: Journal of the American Chemical Society 20060322
Title: [Pharmacotherapy of osteoporosis: evidence-based clinical practice].
Journal: Medizinische Klinik (Munich, Germany : 1983) 20060322
Title: [Therapy of hypercalcemia with ibandronate in case of acute renal failure].
Journal: Der Internist 20060301
Title: Ibandronate treatment for osteoporosis: rationale, preclinical, and clinical development of extended dosing regimens.
Journal: Current osteoporosis reports 20060301
Title: Editorial foreword.
Journal: Therapeutics and clinical risk management 20060301
Title: Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis.
Journal: Therapeutics and clinical risk management 20060301
Title: Differences between the bisphosphonates for the prevention and treatment of osteoporosis.
Journal: Therapeutics and clinical risk management 20060301
Title: Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.
Journal: Cancer research 20060215
Title: A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20060201
Title: Independent pathways in the modulation of osteoclastic resorption by intermediates of the mevalonate biosynthetic pathway: the role of the retinoic acid receptor.
Journal: Bone 20060201
Title: Strategies for the prevention and treatment of osteoporosis during early postmenopause.
Journal: American journal of obstetrics and gynecology 20060201
Title: Update of current therapeutic options for the treatment of postmenopausal osteoporosis.
Journal: Clinical therapeutics 20060201
Title: [Osteoporosis treatment].
Journal: Revue medicale suisse 20060104
Title: Fracture prevention in postmenopausal osteoporosis: a review of treatment options.
Journal: Obstetrical & gynecological survey 20060101
Title: Rapid pain relief and remission of sternocostoclavicular hyperostosis after intravenous ibandronate therapy.
Journal: Journal of bone and mineral metabolism 20060101
Title: The treatment of severe postmenopausal osteoporosis : a review of current and emerging therapeutic options.
Journal: Treatments in endocrinology 20060101
Title: [Present development of new drugs for osteoporosis].
Journal: Clinical calcium 20060101
Title: Osteoporosis in postmenopausal women. Therapy options across a wide range of risk for fracture.
Journal: Geriatrics 20060101
Title: Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines.
Journal: Breast cancer research : BCR 20060101
Title: [Ibandronate once a month].
Journal: Medizinische Monatsschrift fur Pharmazeuten 20060101
Title: Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells.
Journal: BMC cancer 20060101
Title: Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026].
Journal: Breast cancer research : BCR 20060101
Title: Ibandronic acid: a review of its use in the treatment of bone metastases of breast cancer.
Journal: Drugs 20060101
Title: Ibandronate: the evolution of a once-a-month oral therapy for postmenopausal osteoporosis.
Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20060101
Title: Long-term safety of bisphosphonate therapy for osteoporosis: a review of the evidence.
Journal: Drugs & aging 20060101
Title: Psychometric evaluation of the Osteoporosis Patient Treatment Satisfaction Questionnaire (OPSAT-Q), a novel measure to assess satisfaction with bisphosphonate treatment in postmenopausal women.
Journal: Health and quality of life outcomes 20060101
Title: Rapid infusion of ibandronate in lung cancer patients with bone metastases.
Journal: Anticancer research 20060101
Title: Treating osteoporosis with bisphosphonates and addressing adherence: a review of oral ibandronate.
Journal: Drugs 20060101
Title: Sequence- and concentration-dependent effects of acute and long-term exposure to the bisphosphonate ibandronate in combination with single and multiple fractions of ionising radiation doses in human breast cancer cell lines.
Journal: Clinical & experimental metastasis 20060101
Title: In vitro synergistic cytoreductive effects of zoledronic acid and radiation on breast cancer cells.
Journal: Breast cancer research : BCR 20060101
Title: No association between the aluminium content of trabecular bone and bone density, mass or size of the proximal femur in elderly men and women.
Journal: BMC musculoskeletal disorders 20060101
Title: Intravenous ibandronate: in the treatment of osteoporosis.
Journal: Drugs 20060101
Title: Antiepileptic drugs and bone metabolism.
Journal: Nutrition & metabolism 20060101
Title: The role of bisphosphonates in early breast cancer.
Journal: The oncologist 20060101
Title: Ibandronate: its role in metastatic breast cancer.
Journal: The oncologist 20060101
Title: Ibandronate for the treatment of hypercalcemia or nephrocalcinosis in patients with multiple myeloma and acute renal failure: Case reports.
Journal: Acta haematologica 20060101
Title: Non-ulcerating calcific uremic arteriolopathy skin lesion treated successfully with intravenous ibandronate.
Journal: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 20060101
Title: Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role.
Journal: Arthritis research & therapy 20060101
Title: Tolerability of different dosing regimens of bisphosphonates for the treatment of osteoporosis and malignant bone disease.
Journal: Drug safety 20060101
Title: Intravenous ibandronate in the treatment of osteoporosis: profile report.
Journal: Drugs & aging 20060101
Title: Safety of oral ibandronate in the treatment of bone metastases from breast cancer : long-term follow-up experience.
Journal: Clinical drug investigation 20060101
Title: Long-term safety of intravenous ibandronic acid for up to 4 years in metastatic breast cancer: an open-label trial.
Journal: Clinical drug investigation 20060101
Title: [The role of ibandronate in the daily oncological practice].
Journal: Magyar onkologia 20060101
Title: [Ibandronate].
Journal: Reumatizam 20060101
Title: Pharmacologic and nonpharmacologic management of osteoporosis.
Journal: Clinical cornerstone 20060101
Title: [Effects of bisphosphonates on proliferation of lung cancer cells in vitro].
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer 20051220
Title: Cost-effectiveness of oral ibandronate compared with intravenous (i.v.) zoledronic acid or i.v. generic pamidronate in breast cancer patients with metastatic bone disease undergoing i.v. chemotherapy.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20051201
Title: Effective and rapid treatment of painful localized transient osteoporosis (bone marrow edema) with intravenous ibandronate.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20051201
Title: Does avascular necrosis of the jaws in cancer patients only occur following treatment with bisphosphonates?
Journal: Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 20051201
Title: Newer drug treatments: their effects on fracture prevention.
Journal: Best practice & research. Clinical rheumatology 20051201
Title: Acute renal effects of intravenous bisphosphonates in the rat.
Journal: Basic & clinical pharmacology & toxicology 20051201
Title: Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO).
Journal: Current medical research and opinion 20051201
Title: Highlights From ECCO 13-The European Cancer Conference Paris, France October 30 to November 3, 2005.
Journal: Clinical breast cancer 20051201
Title: Ibandronate: a new oral bisphosphonate for postmenopausal osteoporosis.
Journal: The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20051201
Title: Oral ibandronate significantly reduces the risk of vertebral fractures of greater severity after 1, 2, and 3 years in postmenopausal women with osteoporosis.
Journal: Bone 20051101
Title: [Treatment options for hormone-refractory prostate cancer].
Journal: Der Urologe. Ausg. A 20051101
Title: High dosage treatment of nitrogen-containing bisphosphonate ibandronate is required for osseointegration of cementless metal implants.
Journal: Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20051101
Title: S0307. Phase III trial of bisphosphonates as adjuvant therapy for primary breast cancer.
Journal: Clinical advances in hematology & oncology : H&O 20051101
Title: Biological properties and mechanism of action of ibandronate: application to the treatment of osteoporosis.
Journal: Bone 20051001
Title: Safety and tolerability of oral daily and intermittent ibandronate are not influenced by age.
Journal: The Journal of rheumatology 20051001
Title: Oral ibandronate: a less frequently administered therapeutic option for postmenopausal osteoporosis.
Journal: Expert opinion on pharmacotherapy 20051001
Title: Review of treatment modalities for postmenopausal osteoporosis.
Journal: Southern medical journal 20051001
Title: Ibandronate: efficacy in the treatment of metastatic bone disease.
Journal: Future oncology (London, England) 20051001
Title: Analytical methods for the quantification of ibandronate in body fluids and bone.
Journal: Journal of pharmaceutical and biomedical analysis 20050901
Title: Monthly oral ibandronate is well tolerated and efficacious in postmenopausal women: results from the monthly oral pilot study.
Journal: The Journal of clinical endocrinology and metabolism 20050901
Title: Serum proinflammatory mediators at different periods of therapy in patients with multiple myeloma.
Journal: Mediators of inflammation 20050814
Title: The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized rats.
Journal: Bone 20050801
Title: Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20050801
Title: Ibandronate (Boniva): a new oral bisphosphonate.
Journal: Obstetrics and gynecology 20050801
Title: Bone loss and the aromatase inhibitors.
Journal: British journal of cancer 20050801
Title: Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United Kingdom.
Journal: Clinical therapeutics 20050801
Title: Bisphosphonates for breast cancer.
Journal: The Cochrane database of systematic reviews 20050720
Title: The use of bisphosphonates in the treatment of osteoporosis.
Journal: Current opinion in rheumatology 20050701
Title: A new option for osteoporosis.
Journal: The Johns Hopkins medical letter health after 50 20050701
Title: Coculture with dendritic cells promotes proliferation but not cytotoxic activity of gamma/delta T cells.
Journal: Immunology letters 20050615
Title: New therapeutic agents for the treatment of bone diseases.
Journal: Expert opinion on biological therapy 20050601
Title: Efficacy and safety of intravenous bisphosphonates for patients with breast cancer metastatic to bone: a review of randomized, double-blind, phase III trials.
Journal: Clinical breast cancer 20050601
Title: First once-a-month osteoporosis pill approved.
Journal: Harvard women's health watch 20050601
Title: A bright future for osteoporosis treatment.
Journal: Drug news & perspectives 20050601
Title: Longer-lasting osteoporosis drugs sought.
Journal: JAMA 20050525
Title: The prevention and treatment of osteoporosis: a review.
Journal: MedGenMed : Medscape general medicine 20050511
Title: Bisphosphonate inhibitors of Toxoplasma gondi growth: in vitro, QSAR, and in vivo investigations.
Journal: Journal of medicinal chemistry 20050505
Title: Bisphosphonates in breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20050501
Title: Changes in bone structure after augmentation cystoplasty in chronic uraemic rats.
Journal: BJU international 20050501
Title: The issue of renal safety of zoledronic acid from a nephrologist's point of view.
Journal: The oncologist 20050501
Title: 'Safety and convenience of a 15-minute infusion of zoledronic acid': not so safe.
Journal: The oncologist 20050501
Title: New drugs and dosage forms.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050501
Title: Ibandronate (Boniva): a new oral bisphosphonate.
Journal: The Medical letter on drugs and therapeutics 20050425
Title: Should oral bisphosphonates be standard of care in women with early breast cancer?
Journal: Breast cancer research and treatment 20050401
Title: Optimizing the management of postmenopausal osteoporosis with bisphosphonates: the emerging role of intermittent therapy.
Journal: Clinical therapeutics 20050401
Title: Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy and safety results from a randomized, double-blind, placebo-controlled trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20050301
Title: Management of bone metastases in breast cancer.
Journal: Current treatment options in oncology 20050301
Title: Ibandronate for prevention of femoral head deformity after ischemic necrosis of the capital femoral epiphysis in immature pigs.
Journal: The Journal of bone and joint surgery. American volume 20050301
Title: Oral antiresorptive therapy.
Journal: Current rheumatology reports 20050301
Title: Rapid prevention of vertebral fractures associated with osteoporosis.
Journal: Orthopedics 20050301
Title: Ibandronate produces significant, similar antifracture efficacy in North American and European women: new clinical findings from BONE.
Journal: Current medical research and opinion 20050301
Title: Effective doses of ibandronate do not influence the 3-year progression of aortic calcification in elderly osteoporotic women.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20050201
Title: Explicit solutions for a class of indirect pharmacodynamic response models.
Journal: Computer methods and programs in biomedicine 20050201
Title: Ibandronate in metastatic bone disease: a review of preclinical data.
Journal: Anti-cancer drugs 20050201
Title: Oral ibandronic acid.
Journal: IDrugs : the investigational drugs journal 20050201
Title: [Ibandronate as a new therapeutic agent for osteoporosis].
Journal: Clinical calcium 20050101
Title: The role of bisphosphonates in the management of advanced cancer with a focus on non-small-cell lung cancer. Part 1: Mechanisms of action, role of biomarkers and preclinical applications.
Journal: Oncology 20050101
Title: Clinical pharmacology of potent new bisphosphonates for postmenopausal osteoporosis.
Journal: Treatments in endocrinology 20050101
Title: [Monthly tablet].
Journal: Krankenpflege Journal 20050101
Title: New drugs: entecavir, ibandronate sodium, and pegaptanib sodium.
Journal: Journal of the American Pharmacists Association : JAPhA 20050101
Title: Optimizing administration of bisphosphonates in women with postmenopausal osteoporosis.
Journal: Treatments in endocrinology 20050101
Title: Bisphosphonate treatment does not affect serum levels of osteoprotegerin and RANKL in hypercalcemic cancer patients.
Journal: Anticancer research 20050101
Title: [Postmenopausal osteoporosis].
Journal: Krankenpflege Journal 20050101
Title: Anti-resorptive therapy for the prevention of postmenopausal osteoporosis : when should treatment begin?
Journal: Treatments in endocrinology 20050101
Title: Efficacy of ibandronate in metastatic bone disease: review of clinical data.
Journal: The oncologist 20050101
Title: Renal safety of ibandronate.
Journal: The oncologist 20050101
Title: Bisphosphonate treatment recommendations for oncologists.
Journal: The oncologist 20050101
Title: Oral and intravenous ibandronate in the management of postmenopausal osteoporosis: a comprehensive review.
Journal: Current pharmaceutical design 20050101
Title: Once-monthly ibandronate.
Journal: Treatments in endocrinology 20050101
Title: High bone-binding capacity of ibandronate in hemodialysis patients.
Journal: International journal of clinical pharmacology research 20050101
Title: [Zoledronic acid and bone pathology in the course of neoplasia. Part I].
Journal: Tumori 20050101
Title: [Monthly tablet in postmenopausal osteoporosis].
Journal: Krankenpflege Journal 20050101
Title: Rapid administration of ibandronate does not affect renal functioning: evidence from clinical studies in metastatic bone disease and hypercalcaemia of malignancy.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20041201
Title: A semimechanistic and mechanistic population PK-PD model for biomarker response to ibandronate, a new bisphosphonate for the treatment of osteoporosis.
Journal: British journal of clinical pharmacology 20041201
Title: The role of bisphosphonates in breast cancer.
Journal: Breast (Edinburgh, Scotland) 20041201
Title: Ibandronate: its pharmacology and clinical efficacy in the management of tumor-induced hypercalcemia and metastatic bone disease.
Journal: Expert review of anticancer therapy 20041201
Title: Optimizing bisphosphonate therapy in patients with breast cancer on endocrine therapy.
Journal: Seminars in oncology 20041201
Title: [Clinical trial on ibandronate in patients with tumor-associated hypercalcemia].
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology] 20041201
Title: Review of ibandronate in the treatment of metastatic bone disease: experience from phase III trials.
Journal: Clinical therapeutics 20041201
Title: [New treatments in osteoporosis].
Journal: La Revue de medecine interne 20041201
Title: Oral antiresorptive therapy.
Journal: Current osteoporosis reports 20041201
Title: Intermittent ibandronate preserves bone quality and bone strength in the lumbar spine after 16 months of treatment in the ovariectomized cynomolgus monkey.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20041101
Title: Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells.
Journal: British journal of cancer 20041101
Title: Breast tumour growth inhibition in vitro through the combination of cyclophosphamide/metotrexate/5-fluorouracil, epirubicin/cyclophosphamide, epirubicin/paclitaxel, and epirubicin/docetaxel with the bisphosphonates ibandronate and zoledronic acid.
Journal: Oncology reports 20041101
Title: Efficacy and safety of ibandronate in the treatment of neoplastic bone disease.
Journal: Expert opinion on pharmacotherapy 20041101
Title: Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20041001
Title: Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer.
Journal: Pain 20041001
Title: The efficacy and safety of oral ibandronate in the treatment of metastatic bone disease in patients with breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20041001
Title: Targeting Breast Cancer with Care. Proceedings of a meeting. Prague, Czech Republic, February 2004.
Journal: Seminars in oncology 20041001
Title: Bisphosphonates in the treatment of skeletal metastases.
Journal: Seminars in oncology 20041001
Title: Ibandronate reduces skeletal morbidity in patients with breast cancer.
Journal: Seminars in oncology 20041001
Title: Ibandronate in metastatic bone pain.
Journal: Seminars in oncology 20041001
Title: Profiling the safety and tolerability of bisphosphonates.
Journal: Seminars in oncology 20041001
Title: Patient management issues in metastatic bone disease.
Journal: Seminars in oncology 20041001
Title: Managing metastatic bone disease: three case studies.
Journal: Seminars in oncology 20041001
Title: The RIB trial.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain)) 20041001
Title: Systemic and local ibandronate enhance screw fixation.
Journal: Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20040901
Title: Ibandronate: a clinical pharmacological and pharmacokinetic update.
Journal: Journal of clinical pharmacology 20040901
Title: Efficacy and safety of ibandronate in the treatment of opioid-resistant bone pain associated with metastatic bone disease: a pilot study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040901
Title: [Therapy of painful bone metastases in patients with prostate carcinoma. The AP 32/02 Study of the AUO].
Journal: Der Urologe. Ausg. A 20040901
Title: In vitro toxicity of bisphosphonates on human neuroblastoma cell lines.
Journal: Anti-cancer drugs 20040901
Title: Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20040801
Title: Comparative responses of bone turnover markers to bisphosphonate therapy in Paget's disease of bone.
Journal: Bone 20040701
Title: Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer.
Journal: European journal of cancer (Oxford, England : 1990) 20040701
Title: Systematic review of bisphosphonates for hypercalcaemia of malignancy.
Journal: Palliative medicine 20040701
Title: Ibandronate in osteoporosis: preclinical data and rationale for intermittent dosing.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20040601
Title: Surface immobilized bisphosphonate improves stainless-steel screw fixation in rats.
Journal: Biomaterials 20040501
Title: Decreased levels of osteopontin and bone sialoprotein II are correlated with reduced proliferation, colony formation, and migration of GFP-MDA-MB-231 cells.
Journal: International journal of oncology 20040501
Title: Treatment of idiopathic hyperphosphatasia with intensive bisphosphonate therapy.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20040501
Title: Ibandronate and prevention of postmenopausal osteoporosis.
Journal: Annals of the rheumatic diseases 20040501
Title: Bisphosphonates and reduction of skeletal events in patients with bone metastatic breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20040501
Title: Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy and safety results from a randomized, double-blind, placebo-controlled trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20040501
Title: Efficacy and safety of ibandronate given by intravenous injection once every 3 months.
Journal: Bone 20040501
Title: Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis.
Journal: Bone 20040501
Title: Cytostatic and apoptotic effects of bisphosphonates on prostate cancer cells.
Journal: European urology 20040401
Title: [Bone metastases in breast carcinoma. Bisphosphonate protects from complications].
Journal: MMW Fortschritte der Medizin 20040401
Title: Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies.
Journal: British journal of cancer 20040322
Title: Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20040301
Title: Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20040301
Title: Nephrotoxicity of third-generation, intravenous bisphosphonates.
Journal: Toxicology 20040301
Title: Effect of augmentation cystoplasty on bone metabolism in chronic uremic rats.
Journal: The Journal of urology 20040201
Title: [Ibandronate].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20040201
Title: Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat.
Journal: The Journal of biological chemistry 20040116
Title: Quantitative structure-activity relationships for gammadelta T cell activation by bisphosphonates.
Journal: Journal of medicinal chemistry 20040115
Title: Hypercalcemia of malignancy.
Journal: Seminars in nephrology 20040101
Title: Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20040101
Title: Safety and convenience of a 15-minute infusion of zoledronic acid.
Journal: The oncologist 20040101
Title: New model for simulation of fracture repair in full-grown beagle dogs: model characterization and results from a long-term study with ibandronate.
Journal: Journal of pharmacological and toxicological methods 20040101
Title: [Ibandronate: keep life in motion].
Journal: Tumori 20040101
Title: [Oral and parenteral forms of aminobisphosphonate].
Journal: Krankenpflege Journal 20040101
Title: Hormone replacement therapy, calcium and vitamin D3 versus calcium and vitamin D3 alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial [ISRCTN46523456].
Journal: Arthritis research & therapy 20040101
Title: Bisphosphonates: clinical experience.
Journal: The oncologist 20040101
Title: Safety of intravenous and oral bisphosphonates and compliance with dosing regimens.
Journal: The oncologist 20040101
Title: [AIOM Conference 2004. Endocrine therapy and management of patients with bone metastasis of breast cancer].
Journal: Tumori 20040101
Title: [ESMO Conference 2004. Ibandronate in the treatment of bone metastasis].
Journal: Tumori 20040101
Title: Ibandronate improves hyperphosphatemia in dialysis patients with hyperparathyroidism.
Journal: International urology and nephrology 20040101
Title: [How to treat tumor-induced hypercalcemia].
Journal: La Revue du praticien 20031215
Title: Bone resorption predicts for skeletal complications in metastatic bone disease.
Journal: British journal of cancer 20031201
Title: Injectable drug dampens bone loss.
Journal: Health news (Waltham, Mass.) 20031201
Title: [Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].
Journal: Zeitschrift fur Rheumatologie 20031201
Title: Is ibandronate effective in multiple myeloma?
Journal: European journal of haematology 20031201
Title: Use of highly potent bisphosphonates in the treatment of osteoporosis.
Journal: Current osteoporosis reports 20031201
Title: 3-D QSAR investigations of the inhibition of Leishmania major farnesyl pyrophosphate synthase by bisphosphonates.
Journal: Journal of medicinal chemistry 20031120
Title: Bisphosphonates in children with bone diseases.
Journal: The New England journal of medicine 20031120
Title: Site-specific human breast cancer (MDA-MB-231) metastases in nude rats: model characterisation and in vivo effects of ibandronate on tumour growth.
Journal: International journal of cancer 20031110
Title: Follow-up of collagen crosslink excretion in patients with oral squamous cell carcinoma and analysis of tissue samples.
Journal: British journal of cancer 20031103
Title: Ibandronate: new options in the treatment of osteoporosis.
Journal: Drugs of today (Barcelona, Spain : 1998) 20031101
Title: Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women.
Journal: Annals of the rheumatic diseases 20031001
Title: The effects of three-month intravenous ibandronate on bone mineral density and bone remodeling in Klinefelter's syndrome: the influence of vitamin D deficiency and hormonal status.
Journal: Bone 20031001
Title: Efficacy and safety of oral weekly ibandronate in the treatment of postmenopausal osteoporosis.
Journal: The Journal of clinical endocrinology and metabolism 20031001
Title: Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20031001
Title: The renal effects of minimally nephrotoxic doses of ibandronate and zoledronate following single and intermittent intravenous administration in rats.
Journal: Toxicology 20030930
Title: Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20030901
Title: Efficacy and safety of ibandronate in the treatment of hypercalcemia of malignancy: a randomized multicentric comparison to pamidronate.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20030801
Title: Oral weekly ibandronate prevents bone loss in postmenopausal women.
Journal: Journal of internal medicine 20030801
Title: Injectable bisphosphonates in the treatment of postmenopausal osteoporosis.
Journal: Aging clinical and experimental research 20030801
Title: Intravenous ibandronate in men with osteoporosis: an open pilot study over 2 years.
Journal: Journal of endocrinological investigation 20030801
Title: The bisphosphonate ibandronate stimulates reverse cholesterol transport out of monocytoid cells by enhanced ABCA1 transcription.
Journal: Biochemical and biophysical research communications 20030718
Title: Bisphosphonates antagonise bone growth factors' effects on human breast cancer cells survival.
Journal: British journal of cancer 20030707
Title: Dose dependent effects on bone resorption and formation of intermittently administered intravenous ibandronate.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20030701
Title: Lytic bone lesions in human neuroblastoma xenograft involve osteoclast recruitment and are inhibited by bisphosphonate.
Journal: Cancer research 20030615
Title: Three-monthly ibandronate bolus injection offers favourable tolerability and sustained efficacy advantage over two years in established corticosteroid-induced osteoporosis.
Journal: Rheumatology (Oxford, England) 20030601
Title: Oral ibandronate: changes in markers of bone turnover during adequately dosed continuous and weekly therapy and during different suboptimally dosed treatment regimens.
Journal: Bone 20030601
Title: Ibandronate: a potent new bisphosphonate in the management of postmenopausal osteoporosis.
Journal: International journal of clinical practice 20030601
Title: Effects of ibandronate on inflammation in mouse antigen-induced arthritis.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20030501
Title: Role of RANKL-induced osteoclast formation and MMP-dependent matrix degradation in bone destruction by breast cancer metastasis.
Journal: British journal of cancer 20030422
Title: Collagen crosslink excretion and staging of oral cancer.
Journal: British journal of cancer 20030407
Title: The efficacy of 48-week oral ibandronate treatment in postmenopausal osteoporosis when taken 30 versus 60 minutes before breakfast.
Journal: Bone 20030401
Title: Therapy of osteoporosis in patients with Crohn's disease: a randomized study comparing sodium fluoride and ibandronate.
Journal: Alimentary pharmacology & therapeutics 20030315
Title: Review of ibandronate in the treatment of osteoporosis.
Journal: Expert opinion on pharmacotherapy 20030301
Title: Long term effects of a single dose of intravenous Ibandronate.
Journal: Journal of musculoskeletal & neuronal interactions 20030301
Title: Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
Journal: Cancer 20030201
Title: Mechanisms of osteolytic bone metastases in breast carcinoma.
Journal: Cancer 20030201
Title: Antitumor effects of bisphosphonates.
Journal: Cancer 20030201
Title: Antagonistic effects of different classes of bisphosphonates in osteoclasts and macrophages in vitro.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20030201
Title: Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeys.
Journal: Bone 20030101
Title: The diagnosis and management of hypercalcaemia.
Journal: Annals of the Academy of Medicine, Singapore 20030101
Title: Pamidronate is superior to ibandronate in decreasing bone resorption, interleukin-6 and beta 2-microglobulin in multiple myeloma.
Journal: European journal of haematology 20030101
Title: Effect of daily and intermittent use of ibandronate on bone mass and bone turnover in postmenopausal osteoporosis: a review of three phase II studies.
Journal: Clinical therapeutics 20030101
Title: Drugs in development: bisphosphonates and metalloproteinase inhibitors.
Journal: Arthritis research & therapy 20030101
Title: Breast cancer patients with bone metastases are characterised by increased levels of nonisomerised type I collagen fragments.
Journal: Breast cancer research : BCR 20030101
Title: Bisphosphonates in the management of metastatic prostate cancer.
Journal: Oncology 20030101
Title: [Effects of ibandronate on the osteopenia process in tail-suspended rats].
Journal: Aviakosmicheskaia i ekologicheskaia meditsina = Aerospace and environmental medicine 20030101
Title: New insights into the molecular mechanisms of action of bisphosphonates.
Journal: Current pharmaceutical design 20030101
Title: Current management strategies for hypercalcemia.
Journal: Treatments in endocrinology 20030101
Title: Renal safety of intravenous ibandronic Acid in breast cancer patients with metastatic bone disease.
Journal: Clinical drug investigation 20030101
Title: Treatment of hypercalcemia of malignancy with bisphosphonates.
Journal: Seminars in oncology 20021201
Title: Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats.
Journal: Cancer research 20021115
Title: The amino bisphosphonate ibandronate prevents calciphylaxis in the rat at doses that inhibit bone resorption.
Journal: Calcified tissue international 20021001
Title: The effect of the bisphosphonate ibandronate on breast cancer metastasis to visceral organs.
Journal: Breast cancer research and treatment 20021001
Title: Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats.
Journal: The Journal of rheumatology 20021001
Title: Effect of transplantation on bone: osteoporosis after liver and multivisceral transplantation.
Journal: Transplantation proceedings 20020901
Title: Highly potent geminal bisphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa).
Journal: Journal of medicinal chemistry 20020815
Title: Bisphosphonates: biological response modifiers in breast cancer.
Journal: Clinical breast cancer 20020801
Title: An investigation of bone resorption and Dictyostelium discoideum growth inhibition by bisphosphonate drugs.
Journal: Journal of medicinal chemistry 20020704
Title: Activity of bisphosphonates against Trypanosoma brucei rhodesiense.
Journal: Journal of medicinal chemistry 20020704
Title: Elimination of intravenously administered ibandronate in patients on haemodialysis: a monocentre open study.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20020701
Title: Novel therapeutic options for osteoporosis.
Journal: Current opinion in rheumatology 20020701
Title: Bisphosphonates for cancer patients: why, how, and when?
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20020701
Title: [Bone changes in multiple myeloma--current etiopathogenic, diagnostic and therapeutic aspects].
Journal: Vnitrni lekarstvi 20020701
Title: Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products.
Journal: Annals of the rheumatic diseases 20020601
Title: Bisphosphonates influence the proliferation and the maturation of normal human osteoblasts.
Journal: Journal of endocrinological investigation 20020601
Title: Inhibition of geranylgeranyl diphosphate synthase by bisphosphonates and diphosphates: a potential route to new bone antiresorption and antiparasitic agents.
Journal: Journal of medicinal chemistry 20020523
Title: The bisphosphonate zoledronic acid impairs Ras membrane [correction of impairs membrane] localisation and induces cytochrome c release in breast cancer cells.
Journal: British journal of cancer 20020506
Title: Effects of long-term intravenous ibandronate therapy on skeletal-related events, survival, and bone resorption markers in patients with advanced multiple myeloma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020501
Title: Total administered dose of ibandronate determines its effects on bone mass and architecture in ovariectomized aged rats.
Journal: The Journal of rheumatology 20020501
Title: Is there a dose response relationship for clodronate in the treatment of tumour induced hypercalcaemia?
Journal: British journal of cancer 20020422
Title: Bisphosphonates for prevention of postmenopausal osteoporosis.
Journal: Danish medical bulletin 20020201
Title: Ibandronate treatment decreases the effects of tumor-associated lesions on bone density and strength in the rat.
Journal: Bone 20020101
Title: Association between pharmacokinetics of oral ibandronate and clinical response in bone mass and bone turnover in women with postmenopausal osteoporosis.
Journal: Bone 20020101
Title: Bisphosphonates for breast cancer.
Journal: The Cochrane database of systematic reviews 20020101
Title: Direct effects of bisphosphonates on breast cancer cells.
Journal: Breast cancer research : BCR 20020101
Title: The present and future role of bisphosphonates in the management of patients with breast cancer.
Journal: Breast cancer research : BCR 20020101
Title: Development of bisphosphonates.
Journal: Breast cancer research : BCR 20020101
Title: Actions of bisphosphonates in animal models of breast cancer.
Journal: Breast cancer research : BCR 20020101
Title: Safety and efficacy of the new bisphosphonate ibandronate in the management of bone metastasis following rapid infusion.
Journal: In vivo (Athens, Greece) 20020101
Title: Ibandronate in the treatment of prostate cancer associated painful osseous metastases.
Journal: Prostate cancer and prostatic diseases 20020101
Title: Management of primary osteoporosis.
Journal: Acta clinica Belgica 20020101
Title: Ibandronate: a comparison of oral daily dosing versus intermittent dosing in postmenopausal osteoporosis.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20011001
Title: Bisphosphonates in the treatment of metastatic breast cancer.
Journal: Journal of mammary gland biology and neoplasia 20011001
Title: [Radiotherapy and bisphosphonate therapy in bone metastases of prostate carcinoma].
Journal: Praxis 20010920
Title: Should bisphosphonates be the treatment of choice for metastatic bone disease?
Journal: Seminars in oncology 20010801
Title: Dosing regimens and main adverse events of bisphosphonates.
Journal: Seminars in oncology 20010801
Title: Adjuvant bisphosphonate therapy: the future.
Journal: Seminars in oncology 20010801
Title: Effect of ibandronate on bone loss and renal function after kidney transplantation.
Journal: Journal of the American Society of Nephrology : JASN 20010701
Title: The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases.
Journal: Cancer research 20010601
Title: Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption.
Journal: Arteriosclerosis, thrombosis, and vascular biology 20010501
Title: Ibandronate decreases bone disease development and osteoclast stimulatory activity in an in vivo model of human myeloma.
Journal: Experimental hematology 20010401
Title: New advances in the biology and treatment of myeloma bone disease.
Journal: Seminars in hematology 20010401
Title: Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.
Journal: The Journal of pharmacology and experimental therapeutics 20010201
Title: Bisphosphonates induce breast cancer cell death in vitro.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20001101
Title: [TNF-alpha secretion by human macrophage-like cells in response to wear particles and its modification by drugs].
Journal: Biomedizinische Technik. Biomedical engineering 19990501
Title: Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 19980401
Title: Morgan, C., S. Jeremiah, and J. Wagstaff, Metronomic administration of ibandronate and its anti-angiogenic effects in vitro. Microvasc Res, 2009. 78(3): p. 453-8.
Title: Epplen, R., et al., Differential effects of ibandronate, docetaxel and farnesol treatment alone and in combination on the growth of prostate cancer cell lines. Acta Oncol, 2011. 50(1): p. 127-33.
Title: Chesnut, I.C., et al., Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res, 2004. 19(8): p. 1241-9.
Title: Bauss, F., et al., Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats. J Rheumatol, 2002. 29(10): p. 2200-8.
